MCID: ANG018
MIFTS: 46

Angiomyolipoma

Categories: Cancer diseases

Aliases & Classifications for Angiomyolipoma

MalaCards integrated aliases for Angiomyolipoma:

Name: Angiomyolipoma 12 55 44 15 72
Angiomyolipoma of Kidney 72

Classifications:



External Ids:

Disease Ontology 12 DOID:3314
MeSH 44 D018207
NCIt 50 C3734
SNOMED-CT 68 19929002
UMLS 72 C0206633 C0241961

Summaries for Angiomyolipoma

Disease Ontology : 12 A cell type benign neoplasm that is primarily located in the kidneys but may be found in the lungs, liver or other organs and is derived from perivascular epithelioid cells.

MalaCards based summary : Angiomyolipoma, also known as angiomyolipoma of kidney, is related to kidney angiomyolipoma and hepatic angiomyolipoma. An important gene associated with Angiomyolipoma is TSC1 (TSC Complex Subunit 1), and among its related pathways/superpathways are ERK Signaling and Gastric cancer. The drugs Doxycycline and Antimalarials have been mentioned in the context of this disorder. Affiliated tissues include kidney, liver and lung, and related phenotypes are cellular and behavior/neurological

Wikipedia : 75 Angiomyolipomas are the most common benign tumour of the kidney. Although regarded as benign,... more...

Related Diseases for Angiomyolipoma

Diseases related to Angiomyolipoma via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 421, show less)
# Related Disease Score Top Affiliating Genes
1 kidney angiomyolipoma 34.8 TSC2 TSC1 MTOR
2 hepatic angiomyolipoma 33.5 TSC2 MTOR KIT
3 tuberous sclerosis 2 33.2 TSC2 TSC1 MTOR
4 tuberous sclerosis 1 32.4 TSC2 TSC1 MTOR CCL26
5 lymphangioleiomyomatosis 31.7 TSC2 TSC1 PGR MTOR ESR1 DES
6 congenital heart defects, hamartomas of tongue, and polysyndactyly 31.3 TSC2 TSC1 CCL26
7 tuberous sclerosis 31.2 VIM TSC2 TSC1 MTOR CCL26
8 subependymal giant cell astrocytoma 31.0 TSC2 TSC1 MTOR
9 angiolipoma 30.8 VIM DES ACTC1
10 lymphangiectasis 30.6 VIM ACTC1
11 spindle cell sarcoma 30.6 VIM DES ACTC1
12 autosomal dominant polycystic kidney disease 30.4 TSC2 TSC1 MTOR
13 cystic kidney disease 30.4 TSC2 TSC1 CCL26
14 lymphangiomatosis 30.3 VIM PGR DES
15 dedifferentiated liposarcoma 30.2 DES ACTC1
16 glomus tumor 30.2 VIM DES ACTC1
17 hemangiopericytoma, malignant 30.2 VIM DES ACTC1
18 polycystic kidney disease 1 with or without polycystic liver disease 30.2 TSC2 TSC1 MTOR
19 cavernous hemangioma 30.0 VIM KIT DES
20 epithelioid cell melanoma 29.9 TYR MLANA MITF
21 neurilemmoma 29.8 VIM KIT DES
22 renal cell carcinoma, nonpapillary 29.6 VIM TSC2 TSC1 MTOR MITF KIT
23 renal cell carcinoma, papillary, 1 29.5 MTOR MITF KIT
24 sarcoma, synovial 29.5 VIM KIT DES
25 gastrointestinal stromal tumor 29.4 VIM KIT DES ACTC1
26 inflammatory myofibroblastic tumor 29.3 VIM KIT DES ACTC1
27 leiomyosarcoma 29.2 VIM PGR KIT DES ACTC1
28 cystic nephroma 29.1 VIM PGR KIT DES
29 microphthalmia 29.0 TYR MLANA MITF KIT
30 dowling-degos disease 1 29.0 TYR MITF KIT
31 perivascular epithelioid cell tumor 28.8 VIM TSC2 PGR KIT DES ACTC1
32 leiomyoma 28.6 VIM PGR KIT ESR1 DES ACTC1
33 juvenile nasopharyngeal angiofibroma 28.6 PGR KIT ESR1 ACTC1
34 smooth muscle tumor 28.1 VIM PGR KIT ESR1 DES ACTC1
35 childhood kidney angiomyolipoma 12.4
36 epithelioid type angiomyolipoma 12.2
37 multiple endocrine neoplasia, type i 11.2
38 polycystic kidney disease, infantile severe, with tuberous sclerosis 11.2
39 adult hepatocellular carcinoma 10.7 TSC2 TSC1
40 fibroblastic rheumatism 10.7 DES ACTC1
41 infantile digital fibromatosis 10.6 VIM DES
42 cutaneous leiomyosarcoma 10.6 DES ACTC1
43 botryoid rhabdomyosarcoma 10.6 DES ACTC1
44 primitive neuroectodermal tumor of the cervix uteri 10.6 VIM DES
45 glomangioma 10.6 DES ACTC1
46 intravascular papillary endothelial hyperplasia 10.6 VIM ACTC1
47 liposarcoma 10.6
48 lissencephaly with cerebellar hypoplasia 10.6 TSC2 TSC1
49 biphasic synovial sarcoma 10.6 VIM DES
50 non-langerhans-cell histiocytosis 10.6 DES ACTC1
51 rare tumor 10.5
52 adenofibroma 10.5 VIM ACTC1
53 juvenile xanthogranuloma 10.5 VIM DES
54 angiocentric glioma 10.5 VIM ACTC1
55 halo nevi 10.5 TYR MLANA
56 desmoplastic small round cell tumor 10.5 VIM DES
57 ischemic fasciitis 10.5 DES ACTC1
58 pleomorphic liposarcoma 10.5 VIM DES
59 lipomatosis, multiple 10.5
60 pleomorphic lipoma 10.5
61 calcifying aponeurotic fibroma 10.5 PGR ACTC1
62 melanoacanthoma 10.5 TYR MLANA
63 hepatocellular carcinoma 10.5
64 diffuse meningeal melanocytosis 10.5 TYR MLANA
65 myxoid leiomyosarcoma 10.5 PGR ACTC1
66 bizarre leiomyoma 10.5 PGR ACTC1
67 polycystic liver disease 1 with or without kidney cysts 10.4 TSC2 TSC1 ACTC1
68 mesenchymal cell neoplasm 10.4
69 clear cell renal cell carcinoma 10.4
70 extraskeletal ewing sarcoma 10.4 VIM DES
71 large cell acanthoma 10.4 MTOR MLANA
72 oncocytoma 10.4
73 mesenchymal chondrosarcoma 10.4 VIM DES
74 intravenous leiomyomatosis 10.4 ESR1 DES
75 syringocystadenoma papilliferum 10.4 VIM DES ACTC1
76 parachordoma 10.4 VIM DES ACTC1
77 spindle cell lipoma 10.4 VIM DES ACTC1
78 epithelioid leiomyosarcoma 10.4 VIM DES ACTC1
79 ossifying fibromyxoid tumor 10.4 VIM DES ACTC1
80 clear cell meningioma 10.4 VIM PGR
81 congenital fibrosarcoma 10.4 VIM DES ACTC1
82 cutaneous fibrous histiocytoma 10.4 VIM DES ACTC1
83 reticulum cell sarcoma 10.4 VIM DES ACTC1
84 pseudosarcomatous fibromatosis 10.4 VIM DES ACTC1
85 hemangioma 10.4
86 kidney benign neoplasm 10.4 TSC2 MTOR
87 infantile myofibromatosis 10.4 VIM DES ACTC1
88 chondromyxoid fibroma 10.4 VIM DES ACTC1
89 malignant fibroxanthoma 10.4 VIM DES ACTC1
90 subependymal glioma 10.4 TSC2 TSC1 MTOR
91 rhabdoid tumor predisposition syndrome 1 10.4 VIM DES ACTC1
92 benign ependymoma 10.4 TSC2 TSC1 MTOR
93 aneurysm 10.4
94 rare soft tissue tumor 10.4
95 giant cell tumor 10.4 VIM DES ACTC1
96 focal cortical dysplasia, type ii 10.4 TSC2 TSC1 MTOR
97 uterus bicornis bicollis with partial vaginal septum and unilateral hematocolpos with ipsilateral renal agenesis 10.3
98 adenoma 10.3
99 pulmonary embolism 10.3
100 bartholin's gland disease 10.3 PGR MTOR
101 bartholin's gland adenoma 10.3 PGR ESR1
102 vestibular gland benign neoplasm 10.3 PGR ESR1
103 albinism, ocular, with late-onset sensorineural deafness 10.3 TYR MITF
104 lung leiomyoma 10.3 PGR ESR1
105 vulvar syringoma 10.3 PGR ESR1
106 glassy cell carcinoma of the cervix 10.3 PGR ESR1
107 focal epilepsy 10.3 TSC2 TSC1 MTOR
108 vulvar leiomyoma 10.3 PGR ESR1
109 albinism, ocular, with sensorineural deafness 10.3 TYR MITF
110 trigonitis 10.3 PGR ESR1
111 gallbladder melanoma 10.3 MLANA MITF
112 vulvar benign neoplasm 10.3 PGR ESR1
113 pneumothorax 10.3
114 kidney disease 10.3
115 renal oncocytoma 10.3
116 retroperitoneal liposarcoma 10.3
117 plasmablastic lymphoma 10.3 MTOR DES
118 predominantly cortical thymoma 10.3 PGR ESR1
119 epulis 10.3 VIM PGR DES
120 breast scirrhous carcinoma 10.3 PGR ESR1
121 breast medullary carcinoma 10.3 PGR ESR1
122 oncocytic breast carcinoma 10.3 PGR ESR1
123 lentigo maligna melanoma 10.3 MLANA MITF
124 astrocytoma 10.2
125 bartholin's gland benign neoplasm 10.2 PGR ESR1
126 hypomelanosis of ito 10.2 TYR MITF
127 sertoli cell tumor 10.2 VIM PGR
128 congenital epulis 10.2 VIM PGR DES
129 progesterone-receptor positive breast cancer 10.2 PGR ESR1
130 endometrial squamous cell carcinoma 10.2 PGR ESR1
131 progesterone resistance 10.2 PGR ESR1
132 polycystic kidney disease 10.2
133 melanoma 10.2
134 47,xyy 10.2
135 chromophil renal cell carcinoma 10.2
136 apocrine adenocarcinoma 10.2 PGR ESR1
137 synchronous bilateral breast carcinoma 10.2 PGR ESR1
138 vitiligo-associated multiple autoimmune disease susceptibility 6 10.2 TYR MITF
139 gender identity disorder 10.2 PGR ESR1
140 hydronephrosis 10.2
141 pyelonephritis 10.2
142 well-differentiated liposarcoma 10.2
143 end stage renal failure 10.2
144 stomatitis 10.2
145 back pain 10.2
146 syringoma 10.2 VIM ESR1 DES
147 glomangiomyoma 10.2 VIM ESR1 ACTC1
148 cervical carcinosarcoma 10.2 PGR ESR1
149 female reproductive endometrioid cancer 10.2 PGR ESR1
150 tietz albinism-deafness syndrome 10.2 TYR MITF
151 estrogen excess 10.2 PGR ESR1
152 neurofibromatosis, type iv, of riccardi 10.2
153 wilms tumor 5 10.2
154 sarcoma 10.2
155 kidney cancer 10.2
156 chronic kidney disease 10.2
157 gallbladder sarcoma 10.1 KIT DES
158 cervical clear cell adenocarcinoma 10.1 PGR ESR1
159 mammographic density 10.1 PGR ESR1
160 inflammatory breast carcinoma 10.1 PGR ESR1
161 breast cancer 10.1
162 adenocarcinoma 10.1
163 lung disease 10.1
164 48,xyyy 10.1
165 horseshoe kidney 10.1
166 retinitis pigmentosa 47 10.1 PGR ESR1
167 mast-cell sarcoma 10.1 VIM KIT
168 uterine benign neoplasm 10.1 TSC2 PGR ESR1
169 pheochromocytoma 10.1
170 hepatocellular adenoma 10.1
171 adrenal gland pheochromocytoma 10.1
172 thrombosis 10.1
173 respiratory failure 10.1
174 acute cystitis 10.1
175 transitional cell carcinoma 10.1
176 acral lentiginous melanoma 10.1 VIM KIT
177 malignant anus melanoma 10.1 MLANA KIT
178 glycogen-rich clear cell breast carcinoma 10.0 PGR ESR1 ACTC1
179 retinitis pigmentosa 20 10.0 PGR ESR1
180 endometrial mucinous adenocarcinoma 10.0 VIM PGR ESR1
181 ovarian melanoma 10.0 MLANA KIT
182 senile angioma 10.0 VIM KIT
183 deep angioma 10.0 TYR PGR ESR1
184 hypertriglyceridemia, familial 10.0
185 intussusception 10.0
186 pneumothorax, primary spontaneous 10.0
187 multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephaly 10.0
188 budd-chiari syndrome 10.0
189 alveolar soft part sarcoma 10.0
190 retroperitoneal sarcoma 10.0
191 viral hepatitis 10.0
192 lipomatosis 10.0
193 angiomyoma 10.0
194 sarcomatoid renal cell carcinoma 10.0
195 neurofibroma 10.0
196 chromosomal triplication 10.0
197 syncope 10.0
198 rare renal tumor 10.0
199 intramuscular hemangioma 10.0 TYR PGR ESR1
200 pigmented basal cell carcinoma 10.0 TYR MLANA MITF
201 benign metastasizing leiomyoma 10.0 VIM PGR DES ACTC1
202 spindle cell carcinoma 10.0 VIM PGR DES ACTC1
203 endometriosis of ovary 10.0 PGR ESR1
204 ovarian fibrothecoma 9.9 KIT DES ACTC1
205 luminal breast carcinoma 9.9 PGR MTOR ESR1
206 melanoma, uveal 9.9 TYR MLANA MITF
207 pulmonary vein stenosis 9.9 KIT DES ACTC1
208 neurofibromatosis, type ii 9.9
209 fibromuscular dysplasia 9.9
210 thrombophilia due to thrombin defect 9.9
211 von hippel-lindau syndrome 9.9
212 pancreatic cancer 9.9
213 thymoma, familial 9.9
214 mevalonic aciduria 9.9
215 lung cancer susceptibility 3 9.9
216 helix syndrome 9.9
217 angiosarcoma 9.9
218 fibroma 9.9
219 cardiac arrest 9.9
220 liver lipoma 9.9
221 cholelithiasis 9.9
222 hydrocephalus 9.9
223 disseminated intravascular coagulation 9.9
224 nephrosclerosis 9.9
225 portal vein thrombosis 9.9
226 hypothyroidism 9.9
227 cholecystitis 9.9
228 hemangioma of liver 9.9
229 interstitial lung disease 9.9
230 rhabdomyosarcoma 9.9
231 thymoma 9.9
232 teratoma 9.9
233 aortic aneurysm 9.9
234 chromophobe renal cell carcinoma 9.9
235 liver cirrhosis 9.9
236 acute pyelonephritis 9.9
237 malignant mesenchymoma 9.9
238 hepatoblastoma 9.9
239 vasculitis 9.9
240 hard palate cancer 9.9
241 fatty liver disease 9.9
242 congenital hydrocephalus 9.9
243 dendritic cell tumor 9.9
244 soft tissue sarcoma 9.9
245 chronic pain 9.9
246 posttransplant acute limbic encephalitis 9.9
247 rare epilepsy 9.9
248 thyroid carcinoma 9.9
249 estrogen-receptor positive breast cancer 9.9 PGR MTOR ESR1
250 spindle cell liposarcoma 9.9 MLANA KIT
251 embryonal sarcoma 9.9 VIM KIT DES
252 polymorphous low-grade adenocarcinoma 9.9 VIM KIT ACTC1
253 malignant peripheral nerve sheath tumor 9.8 VIM KIT ACTC1
254 amelanotic melanoma 9.8 VIM TYR KIT
255 fibrous histiocytoma 9.8 VIM MITF DES ACTC1
256 perineurioma 9.8 VIM KIT
257 papillary hidradenoma 9.8 PGR KIT
258 uterine corpus cancer 9.8 PGR ESR1
259 cutaneous ganglioneuroma 9.8 MITF KIT
260 vulvar melanoma 9.8 TYR MLANA KIT
261 malignant skin fibrous histiocytoma 9.8 TYR MLANA KIT
262 malignant dermis tumor 9.8 TYR MLANA KIT
263 central nervous system melanocytic neoplasm 9.8 TYR MLANA KIT
264 aortic aneurysm, familial abdominal, 1 9.8
265 bladder diverticulum 9.8
266 colorectal cancer 9.8
267 birt-hogg-dube syndrome 9.8
268 fibrosis of extraocular muscles, congenital, 1 9.8
269 hypercholesterolemia, familial, 1 9.8
270 endosteal hyperostosis, autosomal dominant 9.8
271 leiomyoma, uterine 9.8
272 systemic lupus erythematosus 9.8
273 nephrolithiasis, calcium oxalate 9.8
274 sarcoidosis 1 9.8
275 septooptic dysplasia 9.8
276 renal hypodysplasia/aplasia 1 9.8
277 wilms tumor 1 9.8
278 galactorrhea 9.8
279 lymphoma, hodgkin, classic 9.8
280 osteogenic sarcoma 9.8
281 polycythemia vera 9.8
282 yemenite deaf-blind hypopigmentation syndrome 9.8
283 endometrial cancer 9.8
284 kala-azar 1 9.8
285 aplastic anemia 9.8
286 hepatitis c virus 9.8
287 microvascular complications of diabetes 3 9.8
288 microvascular complications of diabetes 4 9.8
289 microvascular complications of diabetes 6 9.8
290 microvascular complications of diabetes 7 9.8
291 leukemia, acute lymphoblastic 9.8
292 cyanosis, transient neonatal 9.8
293 tumor predisposition syndrome 9.8
294 alacrima, achalasia, and mental retardation syndrome 9.8
295 hyperprolactinemia 9.8
296 hydrops, lactic acidosis, and sideroblastic anemia 9.8
297 deficiency anemia 9.8
298 pulmonary hypertension 9.8
299 adrenal cortical carcinoma 9.8
300 paraganglioma 9.8
301 zollinger-ellison syndrome 9.8
302 chronic venous insufficiency 9.8
303 pain agnosia 9.8
304 colitis 9.8
305 ectopic pregnancy 9.8
306 bone disease 9.8
307 mucositis 9.8
308 intracranial abscess 9.8
309 venous insufficiency 9.8
310 classic type lipoma 9.8
311 lymphocytic leukemia 9.8
312 nasopharyngitis 9.8
313 microinvasive gastric cancer 9.8
314 pre-eclampsia 9.8
315 renal hypertension 9.8
316 chronic pyelonephritis 9.8
317 arteriovenous malformation 9.8
318 pulmonary edema 9.8
319 heart disease 9.8
320 endosalpingiosis 9.8
321 nephrotic syndrome 9.8
322 neutropenia 9.8
323 bronchopneumonia 9.8
324 hepatic coma 9.8
325 acute kidney tubular necrosis 9.8
326 relapsing fever 9.8
327 hepatic encephalopathy 9.8
328 eclampsia 9.8
329 obstructive jaundice 9.8
330 toxic shock syndrome 9.8
331 obstructive hydrocephalus 9.8
332 ascending cholangitis 9.8
333 pericholangitis 9.8
334 pyuria 9.8
335 renovascular hypertension 9.8
336 spontaneous tension pneumothorax 9.8
337 neuroendocrine tumor 9.8
338 vascular disease 9.8
339 neuroendocrine carcinoma 9.8
340 hepatitis c 9.8
341 hepatitis b 9.8
342 ascending colon cancer 9.8
343 cystadenoma 9.8
344 benign mesenchymoma 9.8
345 mesenchymoma 9.8
346 myoma 9.8
347 renal adenoma 9.8
348 idiopathic interstitial pneumonia 9.8
349 endometriosis 9.8
350 acute pancreatitis 9.8
351 glomerulonephritis 9.8
352 acute kidney failure 9.8
353 purpura 9.8
354 duodenal obstruction 9.8
355 pulmonary fibrosis 9.8
356 pituitary adenoma 9.8
357 thrombophlebitis 9.8
358 adrenal carcinoma 9.8
359 pancreatic adenocarcinoma 9.8
360 liver disease 9.8
361 myofibroma 9.8
362 acneiform dermatitis 9.8
363 collecting duct carcinoma 9.8
364 pulmonary coin lesion 9.8
365 bile duct adenoma 9.8
366 gastrinoma 9.8
367 cellular myxoid liposarcoma 9.8
368 giant hemangioma 9.8
369 congestive heart failure 9.8
370 lymphopenia 9.8
371 adrenal adenoma 9.8
372 compartment syndrome 9.8
373 active peptic ulcer disease 9.8
374 situs inversus 9.8
375 appendicitis 9.8
376 polycythemia 9.8
377 intestinal obstruction 9.8
378 ileus 9.8
379 paralytic ileus 9.8
380 ulcerative colitis 9.8
381 leishmaniasis 9.8
382 amyloidosis 9.8
383 liver inflammatory pseudotumor 9.8
384 exophthalmos 9.8
385 hypopituitarism 9.8
386 acute myocardial infarction 9.8
387 cholangitis 9.8
388 aphthous stomatitis 9.8
389 placental abruption 9.8
390 renal tuberculosis 9.8
391 cytokine deficiency 9.8
392 dextrocardia with situs inversus 9.8
393 retroperitoneal fibrosis 9.8
394 multiple endocrine neoplasia 9.8
395 cerebral aneurysms 9.8
396 encephalopathy 9.8
397 fainting 9.8
398 cerebrofacial arteriovenous metameric syndrome 9.8
399 muscle cancer 9.8 PGR KIT DES
400 benign breast phyllodes tumor 9.8 VIM PGR KIT
401 dermoid cyst 9.7 VIM PGR KIT
402 thoracic benign neoplasm 9.7 PGR ESR1
403 undifferentiated pleomorphic sarcoma 9.7 MLANA KIT
404 uterine sarcoma 9.7 KIT ESR1 DES
405 fibromatosis 9.6 VIM KIT DES ACTC1
406 dermatofibrosarcoma protuberans 9.6 VIM KIT DES ACTC1
407 ewing's family of tumors 9.6 MTOR KIT
408 malignant spindle cell melanoma 9.6 TYR MITF KIT
409 cribriform carcinoma 9.6 PGR KIT ESR1
410 adenoid basal cell carcinoma 9.6 PGR KIT ESR1
411 diffuse peritoneal leiomyomatosis 9.6 PGR KIT ESR1
412 peritoneal benign neoplasm 9.6 PGR KIT ESR1
413 breast adenoid cystic carcinoma 9.6 PGR KIT ESR1
414 piebald trait 9.5 TYR MITF KIT
415 breast benign neoplasm 9.5 PGR ESR1
416 waardenburg's syndrome 9.5 TYR MITF KIT
417 adenoid cystic carcinoma 9.5 VIM PGR KIT ACTC1
418 adenosarcoma 9.3 PGR KIT ESR1 DES
419 breast angiosarcoma 9.2 TYR MLANA MITF KIT
420 carcinosarcoma 9.2 VIM PGR KIT DES ACTC1
421 endometrial stromal sarcoma 8.7 VIM PGR KIT ESR1 DES ACTC1

Graphical network of the top 20 diseases related to Angiomyolipoma:



Diseases related to Angiomyolipoma

Symptoms & Phenotypes for Angiomyolipoma

MGI Mouse Phenotypes related to Angiomyolipoma:

46 (showing 16, show less)
# Description MGI Source Accession Score Top Affiliating Genes
1 cellular MP:0005384 10.28 ACTC1 DES ESR1 KIT MITF MTOR
2 behavior/neurological MP:0005386 10.26 DES ESR1 KIT MITF MTOR PGR
3 cardiovascular system MP:0005385 10.25 ACTC1 DES ESR1 KIT MTOR PGR
4 homeostasis/metabolism MP:0005376 10.24 ACTC1 DES ESR1 KIT MITF MTOR
5 mortality/aging MP:0010768 10.2 ACTC1 DES ESR1 KIT MITF MTOR
6 embryo MP:0005380 10.18 ESR1 KIT MITF MTOR PGR TSC1
7 endocrine/exocrine gland MP:0005379 10.11 ESR1 KIT MITF MTOR PGR TSC1
8 integument MP:0010771 10.08 ESR1 KIT MITF MLANA PGR TSC1
9 muscle MP:0005369 10.03 ACTC1 DES ESR1 KIT MTOR PGR
10 nervous system MP:0003631 9.97 ESR1 KIT MITF MTOR TSC1 TSC2
11 neoplasm MP:0002006 9.88 ESR1 KIT PGR TSC1 TSC2 TYR
12 no phenotypic analysis MP:0003012 9.87 ESR1 KIT MITF MLANA MTOR PGR
13 normal MP:0002873 9.86 ACTC1 ESR1 KIT MITF MTOR PGR
14 renal/urinary system MP:0005367 9.63 ESR1 KIT MTOR TSC1 TSC2 TYR
15 reproductive system MP:0005389 9.56 ESR1 KIT MITF PGR TSC1 TSC2
16 skeleton MP:0005390 9.17 ESR1 KIT MITF MTOR PGR TSC1

Drugs & Therapeutics for Angiomyolipoma

Drugs for Angiomyolipoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(showing 41, show less)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Doxycycline Approved, Investigational, Vet_approved Phase 4 564-25-0 54671203
2 Antimalarials Phase 4
3 Antiparasitic Agents Phase 4
4 Antiprotozoal Agents Phase 4
5
Letrozole Approved, Investigational Phase 2 112809-51-5 3902
6
Propranolol Approved, Investigational Phase 2 525-66-6 4946
7
Celecoxib Approved, Investigational Phase 2 169590-42-5 2662
8
Sirolimus Approved, Investigational Phase 2 53123-88-9 6436030 5284616 46835353
9
Everolimus Approved Phase 2 159351-69-6 6442177 70789204
10
Miconazole Approved, Investigational, Vet_approved Phase 2 22916-47-8 4189
11 Estrogens Phase 2
12 Hormones Phase 2
13 Steroid Synthesis Inhibitors Phase 2
14 Hormone Antagonists Phase 2
15 Estrogen Receptor Antagonists Phase 2
16 Estrogen Antagonists Phase 2
17 Aromatase Inhibitors Phase 2
18 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 2
19 Antihypertensive Agents Phase 2
20 Angiogenesis Inhibitors Phase 2
21 Adrenergic Antagonists Phase 2
22 Adrenergic beta-Antagonists Phase 2
23 Neurotransmitter Agents Phase 2
24 Adrenergic Agents Phase 2
25 Anti-Arrhythmia Agents Phase 2
26 Vasodilator Agents Phase 2
27 Anti-Infective Agents Phase 2
28 Anti-Bacterial Agents Phase 2
29 Analgesics Phase 2
30 Cyclooxygenase Inhibitors Phase 2
31 Analgesics, Non-Narcotic Phase 2
32 Peripheral Nervous System Agents Phase 2
33 Cola Phase 2
34 Cyclooxygenase 2 Inhibitors Phase 2
35 Anti-Inflammatory Agents, Non-Steroidal Phase 2
36 Anti-Inflammatory Agents Phase 2
37 Antirheumatic Agents Phase 2
38 Antifungal Agents Phase 2
39 Antibiotics, Antitubercular Phase 2
40 Immunosuppressive Agents Phase 2
41 Immunologic Factors Phase 2

Interventional clinical trials:

(showing 19, show less)
# Name Status NCT ID Phase Drugs
1 CLINICAL TRIAL TO DETERMINE THE EFFICACY AND SAFETY OF RAPAMYCIN IN ANGIOMYOLIPOMAS IN PATIENTS WITH TUBEROUS SCLEROSIS Completed NCT01217125 Phase 4 Sirolimus
2 A Randomised, Double Blind, Placebo Controlled Trial of Doxycycline in Lymphangioleiomyomatosis. Completed NCT00989742 Phase 4 Doxycycline;Placebo
3 Phase IV, Single Arm Study of Safety and Efficacy of Everolimus in Chinese Adults With Tuberous Sclerosis Complex Who Have Renal Angiomyolipoma Not Requiring Immediate Surgery Recruiting NCT03525834 Phase 4 everolimus
4 A Randomized, Double-blind, Placebo-controlled Study of RAD0001 in the Treatment of Angiomyolipoma in Patients With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM) Completed NCT00790400 Phase 3 Everolimus (RAD001);Everolimus Placebo
5 A Phase II Multi-Center Study of Rapamycin for Treating Kidney Angiomyolipomas in TSC or LAM Patients Unknown status NCT00126672 Phase 2 sirolimus
6 Phase II Single Arm Trial With Combination of Everolimus and Letrozole in Treatment of Platinum Resistant Relapse or Refractory or Persistent Ovarian Cancer/Endometrial Cancer (CRAD001CUS242T) Unknown status NCT02188550 Phase 2 everolimus and letrozole
7 Treatment of Renal Angiomyolipomas in Tuberous Sclerosis by Beta-blockers: Pilot Trial Completed NCT02104011 Phase 2 Propranolol
8 Long Term Follow Up for RAD001 Therapy of Angiomyolipomata in Patients With Tuberous Sclerosis Complex and Sporadic Lymphangioleiomyomatosis Completed NCT00792766 Phase 1, Phase 2 everolimus (RAD001)
9 RAD001 Therapy of Angiomyolipomata in Patients With Tuberous Sclerosis Complex and Sporadic Lymphangioleiomyomatosis Completed NCT00457964 Phase 1, Phase 2 RAD001
10 Phase II Study of Everolimus (RAD001, Afinitor®) for Children With Recurrent or Progressive Ependymoma Completed NCT02155920 Phase 2 Everolimus
11 A Pilot Study To Evaluate The Effects of Everolimus on Brain mTOR Activity and Cortical Hyperexcitability in TSC and FCD Recruiting NCT02451696 Phase 2 Everolimus
12 COLA: A Pilot Clinical Trial of COX-2 Inhibition in LAM and TSC Active, not recruiting NCT02484664 Phase 2 Celecoxib
13 A Phase II Study of Sporadic Angiomyolipomas (AMLs) Growth Kinetics While on Everolimus Therapy Terminated NCT02539459 Phase 2 Everolimus
14 A Phase II Study of Orally Administered BEZ235 Monotherapy in Patients With Metastatic or Unresectable Malignant PEComa Withdrawn NCT01690871 Phase 2 BEZ235
15 Tuberous Sclerosis Complex Natural History Study: Renal Manifestations Completed NCT00598455
16 Clinical Presentation and Renal Outcome of Patients With Tuberous Sclerosis Complex and/or Renal Angiomyolipoma in the Great West Region of France Recruiting NCT02887781
17 EASYX-1 : A Multicenter Study on Safety and Efficacy of Easyx Liquid Embolization Agent Used in Five Separate Indications Recruiting NCT03477149
18 Clinical Profile Characterization of Patients With Tuberous Sclerosis Complex, Lymphangioleiomyomatosis and Angiomyolipoma Followed at Hospital Das Clínicas, University of Sao Paulo Medical School Recruiting NCT02325505
19 Epidemiological Study of the Genetic Heterogeneity and Genotype-phenotype Correlation of Children and Adults With Tuberous Sclerosis Complex - An International, Multicenter, Epidemiological Protocol Recruiting NCT02654340

Search NIH Clinical Center for Angiomyolipoma

Cochrane evidence based reviews: angiomyolipoma

Genetic Tests for Angiomyolipoma

Anatomical Context for Angiomyolipoma

MalaCards organs/tissues related to Angiomyolipoma:

41
Kidney, Liver, Lung, Lymph Node, Colon, Smooth Muscle, Adrenal Gland

Publications for Angiomyolipoma

Articles related to Angiomyolipoma:

(showing 3128, show less)
# Title Authors PMID Year
1
Signaling events downstream of mammalian target of rapamycin complex 2 are attenuated in cells and tumors deficient for the tuberous sclerosis complex tumor suppressors. 9 38
19602587 2009
2
PEComas: a review with emphasis on cutaneous lesions. 9 38
20043511 2009
3
The methylation of the TSC2 promoter underlies the abnormal growth of TSC2 angiomyolipoma-derived smooth muscle cells. 9 38
19443708 2009
4
Focal cortical dysplasia: a genotype-phenotype analysis of polymorphisms and mutations in the TSC genes. 9 38
19175396 2009
5
Insight into mechanism of oxidative DNA damage in angiomyolipomas from TSC patients. 9 38
19265534 2009
6
The pathogenesis and imaging of the tuberous sclerosis complex. 9 38
18414839 2008
7
Angiomyolipoma of the anterior mediastinum. 9 38
18620999 2008
8
The mTOR inhibitor rapamycin significantly improves facial angiofibroma lesions in a patient with tuberous sclerosis. 9 38
18547304 2008
9
[Epithelioid renal angiomyolipoma]. 9 38
18592777 2008
10
Constant allelic alteration on chromosome 16p (TSC2 gene) in perivascular epithelioid cell tumour (PEComa): genetic evidence for the relationship of PEComa with angiomyolipoma. 9 38
18085521 2008
11
Coincidence of hepatocelluar carcinoma and hepatic angiomyolipomas in tuberous sclerosis complex: a case report. 9 38
18205279 2008
12
PEComas: the past, the present and the future. 9 38
18080139 2008
13
Anti-EGFR antibody efficiently and specifically inhibits human TSC2-/- smooth muscle cell proliferation. Possible treatment options for TSC and LAM. 9 38
18958173 2008
14
Genetic polymorphisms in OGG1 and their association with angiomyolipoma, a benign kidney tumor in patients with tuberous sclerosis. 9 38
17932460 2008
15
Activation of the mTOR pathway in sporadic angiomyolipomas and other perivascular epithelioid cell neoplasms. 9 38
17521703 2007
16
Survivin expression in tuberous sclerosis complex cells. 9 38
17592551 2007
17
Sporadic subcutaneous angiomyolipoma with expression of estrogen and progesterone receptors. 9 38
17124601 2007
18
[Epithelioid angiomyolipoma of kidney: clinicopathologic study of two cases and review of literature]. 9 38
17374233 2007
19
Differential expression of melanocytic markers in myoid, lipomatous, and vascular components of renal angiomyolipomas. 9 38
17227112 2007
20
Rapid growth of a kidney angiomyolipoma after initiation of oral contraceptive therapy. 9 38
17018483 2006
21
Comparative genomic hybridization study of perivascular epithelioid cell tumor: molecular genetic evidence of perivascular epithelioid cell tumor as a distinctive neoplasm. 9 38
16647959 2006
22
Emerging clinical picture of lymphangioleiomyomatosis. 9 38
16055626 2005
23
Isolation and growth of smooth muscle-like cells derived from tuberous sclerosis complex-2 human renal angiomyolipoma: epidermal growth factor is the required growth factor. 9 38
16192644 2005
24
KIT expression in normal and neoplastic renal tissues: immunohistochemical and molecular genetic analysis. 9 38
15998375 2005
25
C-kit expression in renal oncocytomas and chromophobe renal cell carcinomas. 9 38
15791570 2005
26
Estrogen enhances whereas tamoxifen retards development of Tsc mouse liver hemangioma: a tumor related to renal angiomyolipoma and pulmonary lymphangioleiomyomatosis. 9 38
15781664 2005
27
An epidemiological study of renal pathology in tuberous sclerosis complex. 9 38
15476522 2004
28
Estrogen receptor is significantly associated with the epithelioid variants of renal angiomyolipoma: a clinicopathological and immunohistochemical study of 67 cases. 9 38
15189505 2004
29
Perivascular epithelioid cell tumor of the uterus: immunohistochemical, ultrastructural and molecular study. 9 38
14629307 2003
30
Recurrent lymphangiomyomatosis after transplantation: genetic analyses reveal a metastatic mechanism. 9 38
12411287 2003
31
Mutation in TSC2 and activation of mammalian target of rapamycin signalling pathway in renal angiomyolipoma. 9 38
12711473 2003
32
Renal angiomyolipomas from patients with sporadic lymphangiomyomatosis contain both neoplastic and non-neoplastic vascular structures. 9 38
12547707 2003
33
Functional tyrosine kinase inhibitor profiling: a generally applicable method points to a novel role of platelet-derived growth factor receptor-beta in tuberous sclerosis. 9 38
12213705 2002
34
The TSC-2 product tuberin is expressed in lymphangioleiomyomatosis and angiomyolipoma. 9 38
12010366 2002
35
Expression of KIT (CD117) in angiomyolipoma. 9 38
11914628 2002
36
Renal disease in adults with TSC2/PKD1 contiguous gene syndrome. 9 38
11812941 2002
37
Epithelioid angiomyolipoma of the ovary: a case report and literature review. 9 38
11781527 2002
38
Melanoma markers in angiomyolipoma of the liver and kidney: a comparative study. 9 38
11800647 2002
39
An unusual renal angiomyolipoma with morphological lymphangioleiomyomatosis features and coexpression of oestrogen and progesterone receptors. 9 38
11942568 2002
40
Leiomyomatosis-like lymphangioleiomyomatosis of the colon in a female with tuberous sclerosis. 9 38
11706076 2001
41
[Concomitant occurrence of angiomyolipoma, focal nodular hyperplasia, bile duct adenoma, and cavernous hemangioma in the liver]. 9 38
11766641 2001
42
Chromosome 16 loss of heterozygosity in tuberous sclerosis and sporadic lymphangiomyomatosis. 9 38
11704609 2001
43
The generation and characterization of a cell line derived from a sporadic renal angiomyolipoma: use of telomerase to obtain stable populations of cells from benign neoplasms. 9 38
11485907 2001
44
Renal angiomyolipoma: further immunophenotypic characterization of an expanding morphologic spectrum. 9 38
11371226 2001
45
Immunohistochemical study of microphthalmia transcription factor and tyrosinase in angiomyolipoma of the kidney, renal cell carcinoma, and renal and retroperitoneal sarcomas: comparative evaluation with traditional diagnostic markers. 9 38
11145253 2001
46
Pulmonary lymphangioleiomyomatosis in a man. 9 38
10934115 2000
47
[Clinical and molecular epidemiology of lymphangioleiomyomatosis and pulmonary pathology in tuberous sclerosis]. 9 38
10939121 2000
48
Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis. 9 38
10823953 2000
49
Paratesticular liposarcoma with smooth muscle differentiation mimicking angiomyolipoma. 9 38
10692023 2000
50
Frequent estrogen and progesterone receptor immunoreactivity in renal angiomyolipomas from women with pulmonary lymphangioleiomyomatosis. 9 38
10631194 2000
51
Trabecular angiomyolipoma mimicking hepatic cell carcinoma. 9 38
11033464 2000
52
Expression of melanocyte-associated markers gp-100 and Melan-A/MART-1 in angiomyolipomas. An immunohistochemical and rt-PCR analysis. 9 38
10389626 1999
53
Extension of useful reagent shelf life beyond manufacturers' recommendations. Cell Markers Committee of the College of American Pathologists. 9 38
9870851 1998
54
Malignant tumors of the kidney, brain, and soft tissues in children and young adults with the tuberous sclerosis complex. 9 38
9827727 1998
55
Carcinomalike monotypic epithelioid angiomyolipoma in patients without evidence of tuberous sclerosis: a clinicopathologic and genetic study. 9 38
9630173 1998
56
Clear cell tumor of the lung: an immunohistochemical and ultrastructural study supporting a pericytic differentiation. 9 38
9346179 1997
57
Tuberous sclerosis complex with end-stage renal failure. 9 38
7792029 1995
58
Lymphangiomyomatosis and angiomyolipoma: closely related entities characterized by hamartomatous proliferation of HMB-45-positive smooth muscle. 9 38
8344654 1993
59
Uncommon imaging evolutions of focal liver lesions in cirrhosis. 38
31222462 2019
60
[Review of upper urinary modified minimal invasive surgical technology]. 38
31420609 2019
61
Hepatic angiomyolipoma with early drainage veins into the hepatic and portal vein. 38
30762212 2019
62
A case report of giant hamartoma of both kidneys with spontaneous rupture and hemorrhage in a pregnant woman: A case report. 38
31338191 2019
63
Interesting pancreatic tumour in the background of Tuberous Sclerosis. 38
31383671 2019
64
The Codon 72 TP53 Polymorphism Contributes to TSC Tumorigenesis through the Notch-Nodal Axis. 38
31088907 2019
65
MiT Family Translocation Renal Cell Carcinoma: from the Early Descriptions to the Current Knowledge. 38
31382581 2019
66
Point Shear Wave Elastography Using Machine Learning to Differentiate Renal Cell Carcinoma and Angiomyolipoma. 38
31133445 2019
67
Renal cell carcinomas with a mesenchymal stromal component: what do we know so far? 38
31266596 2019
68
Renal angiomyolipoma. 38
31389508 2019
69
Outcome of Live-Donor Renal Transplants With Incidentally Diagnosed Renal Angiomyolipoma in the Donor. 38
31255355 2019
70
Cytological features of a renal angiomyolipoma in a child-A case report. 38
31293099 2019
71
Hepatic Angiomyolipoma Having FDG Uptake at the Similar Level of the Normal Liver Parenchyma. 38
31135516 2019
72
Comment on "Cutaneous Angiomyolipoma of the Ear: A Case Report and Literature Review" With Report of a Mucosal Lesion. 38
31343426 2019
73
New MRI series for kidney evaluation: Saving time and money. 38
31046410 2019
74
Clinical and morphologic review of 60 hereditary renal tumors from 30 hereditary renal cell carcinoma syndrome patients: lessons from a contemporary single institution series. 38
31332543 2019
75
The value of quantitative CT texture analysis in differentiation of angiomyolipoma without visible fat from clear cell renal cell carcinoma on four-phase contrast-enhanced CT images. 38
31010583 2019
76
[Intratumoral endometriosis in renal angiomyolipomas associated to medium vessel necrotizing vasculitis in a patient with Wünderlich syndrome. A rare finding]. 38
31213263 2019
77
Intravascular papillary endothelial hyperplasia occurring in the foot: A case report and review of literature. 38
31305445 2019
78
Laparoscopic Adrenalectomy: Two Years Experience at Bangabandhu Sheikh Mujib Medical University. 38
31391438 2019
79
Hepatic angiomyolipoma presenting as an arterially enhancing liver lesion. 38
29392818 2019
80
Primary hepatic perivascular epithelioid cell tumors: imaging findings with histopathological correlation. 38
31171030 2019
81
Effect of everolimus on renal function in patients with tuberous sclerosis complex: evidence from EXIST-1 and EXIST-2. 38
30053159 2019
82
Everolimus compliance and persistence among tuberous sclerosis complex patients with renal angiomyolipoma or subependymal giant cell astrocytoma. 38
30550347 2019
83
[The Efficacy of Everolimus for Refractory Seizures in Childhood Onset Epilepsy with Tuberous Sclerosis Complex]. 38
31171758 2019
84
A genome-wide association study implicates NR2F2 in lymphangioleiomyomatosis pathogenesis. 38
31000673 2019
85
Management of Sporadic Renal Angiomyolipomas: A Systematic Review of Available Evidence to Guide Recommendations from the European Association of Urology Renal Cell Carcinoma Guidelines Panel. 38
31171501 2019
86
Angiomyolipoma of the Adrenal Glands. 38
30878377 2019
87
Diagnostic performance of dual-energy CT and subtraction CT for renal lesion detection and characterization. 38
31134365 2019
88
Our experience in emergency treatment of renal haemorrhage. 38
30808522 2019
89
Wunderlich's syndrome in pregnancy: a shocking triad. 38
31110067 2019
90
Trends in clinical, operative, and pathologic characteristics of surgically treated renal mass in a Korean center: A surgical series from 1988 through 2015. 38
31098426 2019
91
Angiomyolipoma of the Kidneys: Current Perspectives and Challenges in Diagnostic Imaging and Image-Guided Therapy. 38
29685402 2019
92
Whole-Tumor Quantitative Apparent Diffusion Coefficient Histogram and Texture Analysis to Differentiation of Minimal Fat Angiomyolipoma from Clear Cell Renal Cell Carcinoma. 38
30087067 2019
93
Concurrent Eosinophilic Solid and Cystic Renal Cell Carcinoma and Angiomyolipoma With Epithelial Cysts in the Setting of Tuberous Sclerosis Complex: A Rare Synchronous Occurrence of 2 Distinct Entities. 38
31142207 2019
94
Use of Iodine Concentration in the Lipid-Poor Portion of the Renal Mass for Differentiation of Angiomyolipoma from Renal Cell Carcinoma. 38
31070481 2019
95
Usefulness of rapid kV-switching dual energy CT in renal tumor characterization. 38
30637472 2019
96
Pediatric Renal Neoplasms:: MR Imaging-Based Practical Diagnostic Approach. 38
30910098 2019
97
Can we predict the existence of extrarenal feeders to renal angiomyolipomas? 38
30542748 2019
98
Nasal Angiomyolipoma (AML) Mimicking Juvenile Nasopharyngeal Angiofibroma. 38
31223601 2019
99
The clinical presentation, imaging features and differential diagnoses of congenital Wilms tumour. 38
31151974 2019
100
Tibial perivascular epithelioid cell tumour (PEComa). A case report and literature review. 38
30905544 2019
101
New radiologic classification of renal angiomyolipoma: frequently asked questions. 38
30825810 2019
102
Two case reports and literature review for hepatic epithelioid angiomyolipoma: Pitfall of misdiagnosis. 38
31119142 2019
103
Percutaneous nephrolithotomy of a staghorn calculus in a patient with renal angiomyolipoma. 38
31040616 2019
104
MR findings of uterine PEComa in patients with tuberous sclerosis: report of two cases. 38
30778737 2019
105
Wunderlich syndrome, spontaneous ruptured renal angiomyolipoma and tuberous sclerosis. 38
30629244 2019
106
Transplant immunosuppressive drugs in urology. 38
31080770 2019
107
Renal and adrenal masses containing fat at MRI: Proposed nomenclature by the society of abdominal radiology disease-focused panel on renal cell carcinoma. 38
30693607 2019
108
Outcome and safety of targeted liver biopsies for indeterminate lesions in patients with chronic liver disease: A single centre experience. 38
30652433 2019
109
Tuberous Sclerosis with Bilateral Angiomyolipoma. 38
31299845 2019
110
Hepatic angiomyolipoma detected using computed tomography. 38
29392859 2019
111
Effect of histopathologic characteristics on pseudocapsular invasion in the case of partial nephrectomy for renal tumours. 38
30691956 2019
112
Renal Angiomyolipoma Based on New Classification: How to Differentiate It From Renal Cell Carcinoma. 38
30620673 2019
113
Correction: miR-9-5p, miR-124-3p, and miR-132-3p regulate BCL2L11 in tuberous sclerosis complex angiomyolipoma. 38
30337693 2019
114
Continuous low-dose everolimus shrinkage tuberous sclerosis complex-associated renal angiomyolipoma: a 48-month follow-up study. 38
30455224 2019
115
Renal angiomyolipoma in patients with tuberous sclerosis complex: findings from the TuberOus SClerosis registry to increase disease Awareness. 38
29697822 2019
116
Embolization of Ruptured Renal Angiomyolipoma in Puerpera. 38
30868552 2019
117
Cutaneous Angiomyolipoma of the Ear: A Case Report and Literature Review. 38
30124505 2019
118
Renal Epithelioid Angiomyolipoma Undergoing Aggressive Clinical Outcome: The MDM2 Expression in Tumor Cells of Two Cases. 38
30799331 2019
119
Efficacy and safety of mTOR inhibitors (rapamycin and its analogues) for tuberous sclerosis complex: a meta-analysis. 38
30760308 2019
120
Coexistent sarcoidosis and lymphangioleiomyomatosis in a patient with cystic lung disease. 38
30519468 2019
121
Differentiation of renal angiomyolipoma without visible fat from renal cell carcinoma by machine learning based on whole-tumor computed tomography texture features. 38
30799634 2019
122
Giant hepatic angiomyolipoma: a case report. 38
31131134 2019
123
Contemporary update on imaging of cystic renal masses with histopathological correlation and emphasis on patient management. 38
30314810 2019
124
Evidence for a role of geranylgeranylation in renal angiomyolipoma and renal epithelioid angiomyolipoma. 38
30675208 2019
125
Late local, peritoneal and systemic recurrence of renal angiomyolipoma: A case report. 38
30655976 2019
126
The differential enhancement pattern of contrast enhanced ultrasound and magnetic resonance imaging characteristics in hepatic angiomyolipoma: 7 case reports. 38
30010112 2019
127
Hepatic Epithelioid Angiomyolipoma Treated with Laparoscopic Resection: Case Report and Review of the Literature. 38
31355023 2019
128
A clinical and surgical challenge: Retrorectal tumors. 38
30880768 2019
129
Tsc1 ablation in Prx1 and Osterix lineages causes renal cystogenesis in mouse. 38
30696882 2019
130
Clinicopathologic analysis of renal epithelioid angiomyolipoma: Consecutively excised 23 cases. 38
30844148 2019
131
Imaging of Unusual Renal Tumors. 38
30663008 2019
132
Spontaneous perirenal hemorrhage (Wunderlich syndrome): An analysis of 28 cases. 38
29779678 2019
133
Tuberous sclerosis complex exhibits a new renal cystogenic mechanism. 38
30675765 2019
134
Malignancy of renal angiomyolipoma from tuberous sclerosis complex with TSC2 mutation. 38
30628968 2019
135
[The 467th case: proteinuria, periungual fibromas, and facial steatadenomas]. 38
30605956 2019
136
Deceased Donor Renal Transplantation Combined with Bilateral Nephrectomy in a Patient with Tuberous Sclerosis and Renal Failure. 38
30963017 2019
137
Recurrent, Giant Renal Angiomyolipoma Treated with Selective Arterial Embolization: A Case Report. 38
29275410 2019
138
Clinical behavior and management of three types of renal angiomyolipomas. 38
29549981 2019
139
Adrenal angiomyolipoma: a rare localization. 38
30457130 2019
140
[Magnetic resonance imaging findings and differential diagnosis of renal epithelioid angiomyolipoma comparing with renal no-epithelioid angiomyolipoma]. 38
30526783 2018
141
Evaluation of ABO blood groups and blood-based biomarkers as a predictor of growth kinetics of renal angiomyolipoma. 38
30324575 2018
142
Quantitative multiparametric MR analysis of small renal lesions: correlation with surgical pathology. 38
29691619 2018
143
Expanding the histomorphologic spectrum of TFE3-rearranged perivascular epithelioid cell tumors. 38
29626599 2018
144
Effect of everolimus treatment for regrown renal angiomyolipoma associated with tuberous sclerosis complex after transcatheter arterial embolization. 38
30069798 2018
145
Burden of renal angiomyolipomas associated with tuberous sclerosis complex: results of a patient and caregiver survey. 38
30294710 2018
146
Genotype-phenotype correlation of patients with tuberous sclerosis complex-associated renal angiomyolipoma: a descriptive study. 38
30036593 2018
147
Retinal astrocytic hamartoma in tuberous sclerosis complex in an elderly person: a case report. 38
30541513 2018
148
Differentiation of Predominantly Solid Enhancing Lipid-Poor Renal Cell Masses by Use of Contrast-Enhanced CT: Evaluating the Role of Texture in Tumor Subtyping. 38
30240299 2018
149
An unusual case of tuberous sclerosis incidentally discovered in adulthood: case report and review of the literature. 38
30619624 2018
150
Giant renal angiomyolipoma in a solitary kidney. 38
30553288 2018
151
Potential for computer-aided diagnosis using a convolutional neural network algorithm to diagnose fat-poor angiomyolipoma in enhanced computed tomography and T2-weighted magnetic resonance imaging. 38
30136400 2018
152
Giant exophytic renal angiomyolipoma masquerading as a retroperitoneal liposarcoma: A case report and review of literature. 38
30425941 2018
153
Renal disease in tuberous sclerosis complex: pathogenesis and therapy. 38
30232410 2018
154
Renal progression factors in young patients with tuberous sclerosis complex: a retrospective cohort study. 38
29987458 2018
155
Immunohistochemical Pitfalls in Genitourinary Pathology: 2018 Update. 38
30157041 2018
156
Sorting the Alphabet Soup of Renal Pathology: A Review. 38
26928791 2018
157
Spontaneous Rupture of Renal Cell Carcinoma in Pregnancy, Surgical Management With Fetal Preservation:A Case Report. 38
29682721 2018
158
The use of rapamycin in patients with tuberous sclerosis complex: Long-term results. 38
30305233 2018
159
Preoperative inferior vena cava filter implantation to prevent pulmonary fat embolism in a patient showing renal angiomyolipoma extension into the renal vein: A case report and literature review. 38
30546809 2018
160
Does epithelioid angiomyolipoma have poorer prognosis, compared with classic angiomyolipoma? 38
30402567 2018
161
Embolization of hemorrhagic renal angiomyolipoma complicated by arteriovenous shunting: A case report. 38
30108678 2018
162
Durable response to anti-PD-1 immunotherapy in epithelioid angiomyolipoma: a report on the successful treatment of a rare malignancy. 38
30285856 2018
163
Author Correction: Microsatellite analysis for differentiating the origin of renal angiomyolipoma and involved regional lymph node. 38
30333562 2018
164
Giant Extrarenal Retroperitoneal Angiomyolipoma: A Rare Case of a Large Size Tumor. 38
29980448 2018
165
Effect of everolimus on skin lesions in patients treated for subependymal giant cell astrocytoma and renal angiomyolipoma: final 4-year results from the randomized EXIST-1 and EXIST-2 studies. 38
29569806 2018
166
Eosinophilic solid and cystic renal cell carcinoma mimicking epithelioid angiomyolipoma: series of 4 primary tumors and 2 metastases. 38
29885406 2018
167
A young female case of primary renal carcinoid tumor mimicking fat-poor angiomyolipoma. 38
31149537 2018
168
Epithelioid angiomyolipoma metastasis to the rectus abdominis. 38
30281012 2018
169
Renal epithelioid angiomyolipoma: magnetic resonance imaging characteristics. 38
29525877 2018
170
Interpreting body MRI cases: classic findings in abdominal MRI. 38
29594465 2018
171
Selecting a suitable surgical treatment for hepatic angiomyolipoma: a retrospective analysis of 92 cases. 38
29241297 2018
172
Fat status detection and histotypes differentiation in solid renal masses using Dixon technique. 38
29414519 2018
173
Evaluation of diagnostic accuracy and a practical algorithmic approach for the diagnosis of renal masses by FNA. 38
30193011 2018
174
Sonographic Features of Small (< 4 cm) Renal Tumors With Low Signal Intensity on T2-Weighted MR Images: Differentiating Minimal-Fat Angiomyolipoma From Renal Cell Carcinoma. 38
30040467 2018
175
Aggressive Renal Angiomyolipoma in a Patient With Tuberous Sclerosis Resulting in Pulmonary Tumor Embolus and Pulmonary Infarction. 38
29885779 2018
176
mTOR inhibitor therapy as a disease modifying therapy for tuberous sclerosis complex. 38
30307123 2018
177
Differentiating solid, non-macroscopic fat containing, enhancing renal masses using fast Fourier transform analysis of multiphase CT. 38
29888982 2018
178
Computed tomography and magnetic resonance imaging of peripelvic and periureteric pathologies. 38
29285599 2018
179
Large Aneurysm in Renal Angiomyolipoma. 38
30173683 2018
180
A rare case of giant renal angiomyolipoma in a woman with tuberous sclerosis. 38
29942788 2018
181
[One case of nasal angiomyolipoma]. 38
30293266 2018
182
Primary kidney malignant epithelioid angiomyolipoma: Two cases report and review of literature. 38
30095646 2018
183
[Comparison of safety and effectiveness between retroperitoneal laparoscopic tumor aspiration and laparoscopic partial nephrectomy in the treatment of renal angiomyolipoma]. 38
30122774 2018
184
Malignant potential of epithelioid angiomyolipomas of the liver: A case report and comprehensive review of the literature. 38
30101028 2018
185
Computed Tomography Perfusion Measurements in Renal Lesions Obtained by Bayesian Estimation, Advanced Singular-Value Decomposition Deconvolution, Maximum Slope, and Patlak Models: Intermodel Agreement and Diagnostic Accuracy of Tumor Classification. 38
29762256 2018
186
A new drug combination significantly reduces kidney tumor progression in kidney mouse model. 38
30250638 2018
187
Diagnostic Imaging for Solid Renal Tumors: A Pictorial Review. 38
30740580 2018
188
[Minimal fat renalangiomyolipoma with multiple lymph nodes enlargement and postoperative refractory lymphatic fistula: a case report and literature review]. 38
30122777 2018
189
Primary angiosarcoma arising in an angiomyolipoma of the kidney: case report and literature review. 38
30111336 2018
190
Ancillary studies in fine needle aspiration of the kidney. 38
30156770 2018
191
Are growth patterns on MRI in small (< 4 cm) solid renal masses useful for predicting benign histology? 38
29492598 2018
192
The efficacy and adverse events of mTOR inhibitors in lymphangioleiomyomatosis: systematic review and meta-analysis. 38
30107845 2018
193
Hepatic epithelioid angiomyolipoma with renal metastasis: radiologic-pathologic correlation. 38
29955240 2018
194
Characterization of small (<4cm) solid renal masses by computed tomography and magnetic resonance imaging: Current evidence and further development. 38
29606371 2018
195
Benign Neoplasm of Kidney: Angiomyolipoma. 38
30283196 2018
196
Efficacy and Safety of Mammalian Target of Rapamycin Inhibitor Use-Long-term Follow-up of First Tuberous Sclerosis Complex Patient Treated De Novo With Sirolimus After Kidney Transplantation: A Case Report. 38
30056926 2018
197
CT features of hepatic epithelioid angiomyolipoma: differentiation from hepatocellular carcinoma in patients with noncirrhotic livers. 38
30140622 2018
198
miR-9-5p, miR-124-3p, and miR-132-3p regulate BCL2L11 in tuberous sclerosis complex angiomyolipoma. 38
29540858 2018
199
Consequences of delay in screening, monitoring, and treatment of angiomyolipoma and tuberous sclerosis: A case report
. 38
29701176 2018
200
Superselective Transcatheter Arterial Embolization for Large Unruptured Renal Angiomyolipoma in Lymphangioleiomyomatosis. 38
29398412 2018
201
Hepatic angiomyolipoma: mutation analysis and immunohistochemical pitfalls in diagnosis. 38
29512829 2018
202
Surveillance imaging for sporadic renal angiomyolipoma less than 40 mm: lessons learnt and recommendations from the experience of a large district general hospital. 38
29658337 2018
203
Re: Diagnostic Performance of CT for Diagnosis of Fat-Poor Angiomyolipoma in Patients with Renal Masses: A Systematic Review and Meta-Analysis. 38
29783555 2018
204
Selective Arterial Embolization of Giant Renal Angiomyolipoma Associated with Tuberous Sclerosis Complex Using Particular and Liquid Embolic Agents. 38
30002583 2018
205
Effect of everolimus treatment for renal angiomyolipoma associated with tuberous sclerosis complex: an evaluation based on tumor density. 38
29256023 2018
206
Intensity ratio curve analysis of small renal masses on T2-weighted magnetic resonance imaging: Differentiation of fat-poor angiomyolipoma from renal cell carcinoma. 38
29577440 2018
207
Editorial Comment to Intensity ratio curve analysis of small renal masses on T2-weighted magnetic resonance imaging: Differentiation of fat-poor angiomyolipoma from renal cell carcinoma. 38
29651812 2018
208
Gemstone spectral imaging dual-energy computed tomography for differentiation of renal cell carcinoma and minimal-fat renal angiomyolipoma. 38
29970695 2018
209
Outcomes of ultrasound guided renal mass biopsies. 38
29696566 2018
210
Retroperitoneal laparoscopic nephron sparing surgery for large renal angiomyolipoma: Our technique and experience. A case series of 41 patients. 38
29723675 2018
211
[CEUS-diagnosis of solid renal tumors]. 38
29767316 2018
212
Hepatic Epithelioid Angiomyolipoma and 18F-FDG PET/CT. 38
29578870 2018
213
Hepatic Angiomyolipoma Staining in the Post-vascular Phase of Contrast-enhanced Ultrasound Due to the Presence of Macrophages. 38
29279500 2018
214
A rare highly aggressive tumor of the kidney: The pure epithelioid angiomyolipoma. 38
29785369 2018
215
Evaluation of renal tumors in children. 38
29733801 2018
216
Chemical shift magnetic resonance imaging for distinguishing minimal-fat renal angiomyolipoma from renal cell carcinoma: a meta-analysis. 38
29178029 2018
217
Differentiation between papillary renal cell carcinoma and fat-poor angiomyolipoma: a preliminary study assessing detection of intratumoral hemorrhage with chemical shift MRI and T2*-weighted gradient echo. 38
29069911 2018
218
Fat poor angiomyolipoma differentiation from renal cell carcinoma at 320-slice dynamic volume CT perfusion. 38
28828638 2018
219
MicroRNA-15a expression measured in urine samples as a potential biomarker of renal cell carcinoma. 38
29549624 2018
220
Postembolization Intratumoral Chronic Bleeding, without the Classic CT Feature of Active Extravasation, in Tuberous Sclerosis Complex-Related Renal Angiomyolipoma: Two Case Reports. 38
29998126 2018
221
Characteristics and healthcare situation of adult patients with tuberous sclerosis complex in German epilepsy centers. 38
29587187 2018
222
Spontaneous reduction of native kidney size involving angiomyolipoma lesions in a kidney transplant recipient with tuberous sclerosis complex. 38
29417638 2018
223
Advanced sporadic renal epithelioid angiomyolipoma: case report of an extraordinary response to sirolimus linked to TSC2 mutation. 38
29764404 2018
224
Two in One: Epithelioid angiomyolipoma within a classic kidney angiomyolipoma - a case report. 38
29843640 2018
225
Expression of MDM2 and p16 in angiomyolipoma. 38
29432785 2018
226
[Renal Angiomyolipoma Extending into the Renal Vein --A Case Report-]. 38
30064160 2018
227
The sunburst sign in renal angiomyolipoma. 38
28828502 2018
228
Extrarenal Angiomyolipoma: differential diagnosis of retroperitoneal masses. 38
29211401 2018
229
Are We Overtreating Renal Angiomyolipoma: A Review of the Literature and Assessment of Contemporary Management and Follow-Up Strategies. 38
29260305 2018
230
Primary adrenal teratoma: An unusual tumor - Challenges in diagnosis and surgical management. 38
29067922 2018
231
Sporadic renal angiomyolipoma in a patient with Birt-Hogg-Dubé: chaperones in pathogenesis. 38
29774133 2018
232
Deep feature classification of angiomyolipoma without visible fat and renal cell carcinoma in abdominal contrast-enhanced CT images with texture image patches and hand-crafted feature concatenation. 38
29474742 2018
233
Machine learning-based quantitative texture analysis of CT images of small renal masses: Differentiation of angiomyolipoma without visible fat from renal cell carcinoma. 38
29134348 2018
234
Renal Angiomyolipoma: The Good, the Bad, and the Ugly. 38
30039053 2018
235
The different faces of renal angiomyolipomas on radiologic imaging: a pictorial review. 38
29327940 2018
236
Quantitative Contour Analysis as an Image-based Discriminator Between Benign and Malignant Renal Tumors. 38
29305199 2018
237
Angiomyolipoma: A link between stemness and tumorigenesis in the kidney. 38
29503451 2018
238
Rupture of renal angiomyolipoma during pregnancy: A case report. 38
30104859 2018
239
An update on recent developments in rupture of renal angiomyolipoma. 38
29668633 2018
240
Inflammatory angiomyolipoma of the liver: a diagnostic pitfall. 38
29496202 2018
241
A rare case of renal angiomyolipoma involved both inferior vena cava and pulmonary arteries. 38
29707365 2018
242
[New approach to diagnosis, immunophenotypic verification and prognostic prediction for renal angiomyolipoma]. 38
29634132 2018
243
Assessing the outcomes of everolimus on renal angiomyolipoma associated with tuberous sclerosis complex in China: a two years trial. 38
29587809 2018
244
Morphologic analysis with computed tomography may help differentiate fat-poor angiomyolipoma from renal cell carcinoma: a retrospective study with 602 patients. 38
28677004 2018
245
t(6;11) renal cell carcinoma: a study of seven cases including two with aggressive behavior, and utility of CD68 (PG-M1) in the differential diagnosis with pure epithelioid PEComa/epithelioid angiomyolipoma. 38
29052596 2018
246
Efficacy and safety of transbronchial lung biopsy for the diagnosis of lymphangioleiomyomatosis: A report of 24 consecutive patients. 38
28960664 2018
247
Different MRI-defined tuber types in tuberous sclerosis complex: Quantitative evaluation and association with disease manifestations. 38
29258718 2018
248
Factors associated with the number and size of renal angiomyolipomas in sporadic angiomyolipoma (sAML): a study of adult patients with sAML managed in a Dutch tertiary referral center. 38
29333579 2018
249
Long-term outcome of robotic partial nephrectomy for renal angiomyolipoma. 38
27955873 2018
250
Huge retroperitoneal epithelioid angiomyolipoma: A case report. 38
29276686 2018
251
Renal angiomyolipoma without visible fat: Can we make the diagnosis using CT and MRI? 38
28779401 2018
252
Massive hematuria at pregnancy caused by ruptured angiomyolipoma: A case report. 38
29254628 2018
253
Acute haemorrhage from a retroperitoneal liposarcoma: a rare presentation. 38
29437802 2018
254
[A Case of Bilateral Angiomyolipoma Accompanied by Tuberous Sclerosis Complex Successfully Treated with Transcatheter Arterial Embolization Using Functional Kidney Mapping Images Consisting of SPECT-CT and Contrast Enhanced CT Images]. 38
29684949 2018
255
mTOR Inhibition and Kidney Diseases. 38
29369972 2018
256
Giant Renal Angiomyolipoma Following Ovarian Stimulation Therapy. 38
29154983 2018
257
PNL2: an adjunctive biomarker for renal angiomyolipomas and perivascular epithelioid cell tumours. 38
28837273 2018
258
[The role of contrast-enhanced pulse inversion harmonic imaging (CEUS) and contrast-enhanced computed tomography (CECT) in the preoperative diagnosis of renal lesions]. 38
29387906 2018
259
Atypical Epithelioid Angiomyolipoma: A Rare Variant With Malignant Potential. 38
28993216 2018
260
Secondary stone formation over a suture material after partial nephrectomy. 38
29298785 2018
261
Dia-gnostic Challenges and Extraordinary Treatment Response in Rare Malignant PEComa Tumor of the Kidney. 38
30545225 2018
262
Kidney transplantation from a living donor to a mentally disabled recipient with bilateral angiomyolipomas-A case report. 38
30567065 2018
263
Malignant renal epithelioid angiomyolipoma with TFE3 gene amplification mimicking renal carcinoma. 38
29951351 2018
264
Laparoscopic partial nephrectomy with prior superselective embolisation as treatment for giant renal angiomyolipoma. 38
28803678 2018
265
Hepatic myomatous angiomyolipoma diagnosedpreoperatively from specific imaging features: A case report. 38
30273908 2018
266
Human renal angiomyolipoma cells of male and female origin can migrate and are influenced by microenvironmental factors. 38
29920561 2018
267
Clinico-pathological correlation of hepatic angiomyolipoma: a series of 23 resection cases. 38
28122404 2018
268
Imaging appearance of renal epithelioid angiomyolipoma: A case report and literature review. 38
29505538 2018
269
Angiomyolipoma of the Liver without a Fat Component, Mimicking a Hepatocellular Carcinoma. 38
29361814 2018
270
Comparison of MRI Features of Epithelioid Hepatic Angiomyolipoma and Hepatocellular Carcinoma: Imaging Data From Two Centers. 38
30619742 2018
271
Disseminated Intravascular Coagulation After Embolization to Treat Acutely Bleeding Bilateral Massive Angiomyolipoma: A Case Report. 38
30065960 2018
272
Everolimus. 38
30069763 2018
273
Bilateral Giant Renal Angiomyolipoma in a Patient with Tuberous Sclerosis Complex: A Case Report. 38
29686177 2018
274
Angiomyolipoma rebound tumor growth after discontinuation of everolimus in patients with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis. 38
30192751 2018
275
Observational study of characteristics and clinical outcomes of Dutch patients with tuberous sclerosis complex and renal angiomyolipoma treated with everolimus. 38
30439947 2018
276
The effect of everolimus on renal angiomyolipoma in pediatric patients with tuberous sclerosis being treated for subependymal giant cell astrocytoma. 38
28993887 2018
277
Rapamycin-independent IGF2 expression in Tsc2-null mouse embryo fibroblasts and human lymphangioleiomyomatosis cells. 38
29758070 2018
278
mTORC1 Inhibition Is an Effective Treatment for Sporadic Renal Angiomyolipoma. 38
29340326 2018
279
Extrarenal retroperitoneal angiomyolipoma with oncocytoma. 38
29343920 2018
280
New Hybrid Mini-laparoendoscopic Single-site Partial Nephrectomy With Early Unclamped Technique for Renal Tumors With Intermediate PADUA Score (IDEAL Phase 2a). 38
29024738 2018
281
Pulmonary lymphangioleiomyomatosis associated with aggressive renal angiomyolipoma. 38
29686563 2018
282
An Inguinal Perivascular Epithelioid Cell Tumor Metastatic to the Orbit. 38
30002939 2018
283
Gastric Angiomyolipoma Masquerading as Gastric Malignancy. 38
30643840 2018
284
Transarterial Embolization of a Ruptured Renal Angiomyolipoma. 38
29021483 2018
285
Epithelioid Angiomyolipoma of the Liver. 38
29110191 2018
286
Fibrinolytic System Changes in Liver Surgery: A Pilot Observational Study. 38
30255021 2018
287
Transcatheter Arterial Embolization for Renal Angiomyolipoma Using a Micro-balloon Catheter and a Mixture of Ethanol and Lipiodol. 38
28685379 2017
288
Peroxisome proliferator-activated receptor gamma (PPARγ) is central to the initiation and propagation of human angiomyolipoma, suggesting its potential as a therapeutic target. 38
29196313 2017
289
[Laparoscopic transperitoneal partial nephrectomy for a tumor of the upper segment]. 38
29376604 2017
290
Urokinase-type plasminogen activator (uPA) is critical for progression of tuberous sclerosis complex 2 (TSC2)-deficient tumors. 38
28972182 2017
291
Clinical and genetic analysis of tuberous sclerosis complex-associated renal angiomyolipoma in Chinese pedigrees. 38
29344138 2017
292
Familial genetic tuberous sclerosis complex associated with bilateral giant renal angiomyolipoma: A case report. 38
29344140 2017
293
Duodenal angiomyolipoma with multiple systemic vascular malformations and aneurysms: A case report and literature review. 38
29151912 2017
294
[Current situation and prospect of diagnosis and treatment of tuberous sclerosis related renal angiomyolipoma]. 38
29224261 2017
295
Recommendations for imaging-based diagnosis and management of renal angiomyolipoma associated with tuberous sclerosis complex. 38
29225800 2017
296
Pulmonary Lymphangiomyomatosis Associated with Renal and Hepatic Angiomyolipoma Mass in a Patient with Tuberous Sclerosis Complex. 38
29237943 2017
297
Effects of everolimus on tuberous sclerosis complex-associated renal angiomyolipoma: A preliminary report. 38
27565896 2017
298
Wunderlich's Syndrome, or Spontaneous Retroperitoneal Hemorrhage, in a Patient with Tuberous Sclerosis and Bilateral Renal Angiomyolipoma. 38
29217816 2017
299
Diagnostic Performance of CT for Diagnosis of Fat-Poor Angiomyolipoma in Patients With Renal Masses: A Systematic Review and Meta-Analysis. 38
28834444 2017
300
Angiomyolipoma of the Liver: A Rare Benign Tumor Treated with a Laparoscopic Approach for the First Time. 38
29102941 2017
301
Evidence of renal angiomyolipoma neoplastic stem cells arising from renal epithelial cells. 38
29133867 2017
302
Notch transactivates Rheb to maintain the multipotency of TSC-null cells. 38
29184052 2017
303
Intermittent everolimus administration for renal angiomyolipoma associated with tuberous sclerosis complex. 38
28905429 2017
304
Editorial Comment to Intermittent everolimus administration for renal angiomyolipoma associated with tuberous sclerosis complex. 38
28905424 2017
305
Renal Angiomyolipoma With Incidental Oncocytoma: A Case Report and Review of Literature. 38
29088523 2017
306
Changing etiology and management patterns for spontaneous renal hemorrhage: a systematic review of contemporary series. 38
28871505 2017
307
Renal epithelioid angiomyolipoma: MRI findings. 38
28695453 2017
308
[A Case of Extrarenal Retroperitoneal Angiomyolipoma]. 38
29394629 2017
309
Cryoablation of Renal Angiomyolipoma: An Evaluation of Safety and Efficacy. 38
28830229 2017
310
Renal Angiomyolipoma: Radiologic Classification and Imaging Features According to the Amount of Fat. 38
28726505 2017
311
Tumoral vascular pattern in renal cell carcinoma and fat-poor renal angiomyolipoma as a novel helpful differentiating factor on contrast-enhanced CT scan. 38
28990498 2017
312
Tuberous sclerosis-associated renal angiomyolipoma: A report of two cases and review of the literature. 38
29046802 2017
313
Ascending cholangitis: rare presentation of a ruptured right-sided renal angiomyolipoma. 38
29026516 2017
314
Phosphaturic Mesenchymal Tumors: Clinicopathologic, Immunohistochemical and Molecular Analysis of 22 Cases Expanding their Morphologic and Immunophenotypic Spectrum. 38
28614212 2017
315
The Histopathological Features and CT/MRI Imaging Performances in Hepatic Angiomyolipoma Patients. 38
31153535 2017
316
The Histopathological Features and CT/MRI Imaging Performances in Hepatic Angiomyolipoma Patients. 38
28809731 2017
317
Renal Tumors of Childhood: Radiologic-Pathologic Correlation Part 2. The 2nd Decade: From the Radiologic Pathology Archives. 38
28898190 2017
318
Chromophobe Renal Cell Carcinoma and the Synchronous Presence of Primary Colon Malignancies. Is There a Relation? 38
28607876 2017
319
Renal angiomyoadenomatous tumour. 38
28861315 2017
320
Clinicopathologic Patterns of Adult Renal Tumors. 38
30787796 2017
321
Active Surveillance of Nonfatty Renal Masses in Patients With Lymphangioleiomyomatosis: Use of CT Features and Patterns of Growth to Differentiate Angiomyolipoma From Renal Cancer. 38
28678574 2017
322
CT imaging of solid renal masses: pitfalls and solutions. 38
28592361 2017
323
Angiomyolipoma of the Glabellar Region. 38
29090203 2017
324
Angiomyolipoma of the Adrenal Gland: A Report of Two Cases and Review of the Literature. 38
28904331 2017
325
Management of hepatic angiomyolipoma: A systematic review. 38
28177188 2017
326
Clinical presentations and molecular studies of invasive renal epithelioid angiomyolipoma. 38
28547571 2017
327
Ruptured angiomyolipoma of the kidney: a rare differential diagnosis of flank pain. 38
28398159 2017
328
Laparoscopic Radiofrequency Ablation Combined with Surgical Excision for Exophytic Renal Angiomyolipoma: A Novel Technique Based on Tumor Vasculature Features of Enhancing Renal Masses Toward Hilar Off-Clamping Nephron-Sparing Surgery. 38
27805457 2017
329
Imaging features of solid renal masses. 38
28590813 2017
330
Primary cutaneous perivascular epithelioid cell tumor (PEComa): Five new cases and review of the literature. 38
28556973 2017
331
Renal tumors with low signal intensities on T2-weighted MR image: radiologic-pathologic correlation. 38
28260171 2017
332
18F-FDG PET/CT of Malignant Angiomyolipoma With Tumor Thrombus. 38
28525455 2017
333
Epithelioid Angiomyolipoma - a case report and review of the literature. 38
29341516 2017
334
Re: Small (< 4 cm) Renal Tumors with Predominantly Low Signal Intensity on T2-Weighted Images: Differentiation of Minimal-Fat Angiomyolipoma from Renal Cell Carcinoma. 38
29370605 2017
335
Giant renal angiomyolipoma: A case report. 38
28781806 2017
336
Everolimus in pregnancy: Case report and literature review. 38
28557245 2017
337
Huge buccal angiomyolipoma: a rare entity. 38
28918977 2017
338
Stepwise algorithm using computed tomography and magnetic resonance imaging for diagnosis of fat-poor angiomyolipoma in small renal masses: Development and external validation. 38
28600877 2017
339
Monoexponential, biexponential, and stretched exponential diffusion-weighted imaging models: Quantitative biomarkers for differentiating renal clear cell carcinoma and minimal fat angiomyolipoma. 38
27859853 2017
340
Can "Tumor-to-Cortex Echogenicity Ratio" Differentiate Angiomyolipomas from Other Hyper-Echoic Renal Masses. 38
28400076 2017
341
Nasal angiomyolipoma: Report of two cases of an extremely rare entity. 38
28937379 2017
342
Retroperitoneal extrarenal angiomyolipoma at the surgical bed 8 years after a renal angiomyolipoma nephrectomy: A case report and review of literature. 38
28794601 2017
343
Patient and nonradiographic tumor characteristics predicting lipid-poor angiomyolipoma in small renal masses: Introducing the BEARS index. 38
28681032 2017
344
Tsc2 disruption in mesenchymal progenitors results in tumors with vascular anomalies overexpressing Lgals3. 38
28695825 2017
345
Treatment of Renal Angiomyolipoma and Other Hamartomas in Patients with Tuberous Sclerosis Complex. 38
28302901 2017
346
Natural history of patients with tuberous sclerosis complex related renal angiomyolipoma. 38
28358266 2017
347
Treatment of renal angiomyolipoma in tuberous sclerosis complex (TSC) patients. 38
27585680 2017
348
Concurrent Oncocytoma and Two Angiomyolipomas in a Diabetic Kidney: A Very Rare Condition. 38
28918618 2017
349
Quantitative computer-aided diagnostic algorithm for automated detection of peak lesion attenuation in differentiating clear cell from papillary and chromophobe renal cell carcinoma, oncocytoma, and fat-poor angiomyolipoma on multiphasic multidetector computed tomography. 38
28280876 2017
350
Differentiation of fat-poor angiomyolipoma from clear cell renal cell carcinoma in contrast-enhanced MDCT images using quantitative feature classification. 38
28376281 2017
351
[Application of mini-flank open nephron sparing surgery via retroperitoneal route for centrally located renal tumor treatment: a single center experience]. 38
28763900 2017
352
Distinct subcellular localization of E-cadherin between epithelioid angiomyolipoma and triphasic angiomyolipoma: A preliminary case-control study. 38
28693223 2017
353
Renal epithelioid angiomyolipoma in a patient with tuberous sclerosis. 38
25580845 2017
354
Benevolent Renal Angiomyolipoma with Intra-cardiac Extension-A Challenge in Diagnosis and Management. 38
28659682 2017
355
Elective and Emergency Renal Angiomyolipoma Embolization with Ethylene Vinyl Alcohol Copolymer: Feasibility and Initial Experience. 38
28291715 2017
356
Primary perivascular epithelioid cell tumors of the liver: CT/MRI findings and clinical outcomes. 38
28246920 2017
357
[Clinical and pathologic analysis of 414 cases of renal angiomyolipomain in a single institution]. 38
28591983 2017
358
Dynamic Contrast-enhanced MRI in Renal Tumors: Common Subtype Differentiation using Pharmacokinetics. 38
28596583 2017
359
[A Case of Epithelioid Angiomyolipoma of the Kidney with Tumor Thrombus Extending into the Renal Vein : Case Report]. 38
28694416 2017
360
Occult Renal Cell Carcinoma of Eosinophilic Morphology Detected within Renal Angiomyolipoma Mass in a Patient with Tuberous Sclerosis Complex. 38
28584217 2017
361
Wunderlich Syndrome due to Ruptured Pseudoaneurysm of Angiomyolipoma in First Trimester: A Rare Case Report. 38
28764248 2017
362
Angiomyolipoma of the scrotum: report of a rarely seen case and review of the literature. 38
28717551 2017
363
A case of ruptured hepatic angiomyolipoma in a young male. 38
28449573 2017
364
Pre-operative renal artery embolization and suprarenal IVC filter placement for prevention of fat embolization in renal angiomyolipoma with venous extension. 38
28167283 2017
365
Re: Jaimin R. Bhatt, Patrick O. Richard, Nicole S. Kim, et al. Natural History of Renal Angiomyolipoma (AML): Most Patients with Large AMLs >4cm Can Be Offered Active Surveillance as an Initial Management Strategy. Eur Urol 2016;70:85-90. 38
27769715 2017
366
The Role of Interventional Radiology Techniques in the Management of Renal Angiomyolipomas. 38
28299630 2017
367
Subjective and objective heterogeneity scores for differentiating small renal masses using contrast-enhanced CT. 38
28025654 2017
368
Angiomyolipoma of the Adrenal Gland: A Case Presentation and a Review of Adrenal Lipomatous Tumors. 38
28367409 2017
369
Tuberous sclerosis complex (Bourneville-Pringle disease) in a 25-year- old female with bilateral renal angiomyolipoma and secondary hypertension. 38
28540905 2017
370
Outcomes of angioembolization and nephrectomy for renal angiomyolipoma associated with tuberous sclerosis complex: a real-world US national study. 38
28112545 2017
371
Beneficial Effects of Everolimus on Autism and Attention-Deficit/Hyperactivity Disorder Symptoms in a Group of Patients with Tuberous Sclerosis Complex. 38
27797585 2017
372
Immunohistochemical approach for the diagnosis of a liver mass on small biopsy specimens. 38
28087475 2017
373
Renal angiomyolipoma with para-aortic lymph node involvement. 38
28271585 2017
374
Successful thoracoscopic resection of a large mediastinal angiomyolipoma. 38
28616301 2017
375
Renal mass biopsy using Raman spectroscopy identifies malignant and benign renal tumors: potential for pre-operative diagnosis. 38
28415596 2017
376
Fluorine-18-FDG PET/CT in a patient with angiomyolipoma: Response to mammalian target of rapamycin inhibitor therapy. 38
28697195 2017
377
Asymptomatic bilateral giant angiomyolipoma. 38
28540918 2017
378
Challenge of FNA diagnosis of angiomyolipoma: A study of 33 cases. 38
28152270 2017
379
Peroxisome proliferator-activated receptor gamma (PPARγ) is central to the initiation and propagation of human angiomyolipoma, suggesting its potential as a therapeutic target 38
28275008 2017
380
[Laparoscopic Non-Ischemic Partial Nephrectomy Using a Microwave Tissue Coagulator : A Single-Institutional Study]. 38
28506049 2017
381
Pulmonary metastasis from renal epithelioid angiomyolipoma in the setting of breast cancer. 38
28433983 2017
382
Office-based Ultrasound-guided Renal Core Biopsy Is Safe and Efficacious in the Management of Small Renal Masses. 38
28024966 2017
383
Partial Nephrectomy for Presumed Renal-Cell Carcinoma: Incidence, Predictors, and Perioperative Outcomes of Benign Lesions. 38
28068796 2017
384
Invasive Renal Angiomyolipoma With Cytologic Atypia. 38
27596442 2017
385
[Epithelioid angiomyolipoma of the kidney: About one case and malignant features evaluation]. 38
28318774 2017
386
Healthcare utilization and costs in patients with tuberous sclerosiscomplex-related renal angiomyolipoma. 38
27998195 2017
387
Hepatic epithelioid angiomyolipoma: clinical features and imaging findings of contrast-enhanced ultrasound and CT. 38
27890423 2017
388
Renal myolipoosteoma: A distinctive lesion in a child. 38
28317591 2017
389
Microsatellite analysis for differentiating the origin of renal angiomyolipoma and involved regional lymph node. 38
28336972 2017
390
Primary hepatic angiomyolipoma: immunohistochemistry and electron microscopic observations: a case report. 38
28327196 2017
391
Ang-1 and Ang-2 expression in angiomyolipoma and PEComa family tumors. 38
28053374 2017
392
[Tuberous Sclerosis Complex Detected by Spontaneous Rupture of a Giant Renal Angiomyolipoma : A Case Report]. 38
28331168 2017
393
RE: Distinguishing between Renal Cell Carcinoma and Fat Poor Angiomyolipoma in Diffusion-Weighted Imaging. 38
28246523 2017
394
Hepatobiliary and Pancreatic: Hepatocellular carcinoma developed with angiomyolipoma. 38
28320064 2017
395
Spontaneous rupture of angiomyolipoma of the kidney. 38
28188380 2017
396
Pelvic lymphangioleiomyomatosis treated successfully with everolimus: Two case reports with literature review. 38
28272193 2017
397
Cesarean Section Revealing an Unsuspected Renal Angiomyolipoma in a Woman with Severe Hypertension During Pregnancy: A Case Report. 38
30230799 2017
398
Epithelioid angiomyolipoma of the liver: a case report. 38
28301898 2017
399
Aetiology, imaging features, and evolution of spontaneous perirenal haemorrhage. 38
27720441 2017
400
False Positive Diagnosis of Hepatocellular Carcinoma in Liver Resection Patients. 38
28049244 2017
401
[What can/should be treated in kidney tumors and when]. 38
28130580 2017
402
Renal cell carcinoma: applicability of the apparent coefficient of the diffusion-weighted estimated by MRI for improving their differential diagnosis, histologic subtyping, and differentiation grade. 38
27853915 2017
403
Diagnosis of Renal Angiomyolipomas: Classic, Fat-Poor, and Epithelioid Types. 38
28237279 2017
404
Pediatric Renal Angiomyolipomas in Tuberous Sclerosis Complex. 38
27678300 2017
405
Efficacy of Everolimus for Treating Renal Angiomyolipoma with Inferior Vena Cava Thrombus Associated with Tuberous Sclerosis: A Case Report. 38
28083476 2017
406
Selective arterial embolization of symptomatic and asymptomatic renal angiomyolipomas: a retrospective study of safety, outcomes and tumor size reduction. 38
28275556 2017
407
Radiological diagnosis of perinephric pathology: pictorial essay 2015. 38
28050791 2017
408
[Operation for Intracardiac Angiomyolipoma;Report of a Case]. 38
28174407 2017
409
Migrated Hem-o-Lok clips in the ureter: a rare cause of recurrent urinary tract infection. 38
28202487 2017
410
Combination of Everolimus with Sorafenib for Solid Renal Tumors in Tsc2+/- Mice Is Superior to Everolimus Alone. 38
28092822 2017
411
Invasive Epithelioid Angiomyolipoma with Tumor Thrombus in the Inferior Vena Cava: A Case Report and Literature Review. 38
26159694 2017
412
Effectiveness and safety of laparoscopic enucleation combined with selective arterial embolization for renal angiomyolipoma. 38
28387661 2017
413
[HUGE RENAL ANGIOMYOLIPOMA COMPLICATED WITH COMMON ILIAC VEIN THROMBUS BECAUSE OF THE TUMOR PRESSURE]. 38
29669983 2017
414
[Aggressive renal angiomyolipoma extending to the renal vein: about a case and literature review]. 38
29599888 2017
415
Super-Selective Artery Embolization before Laparoscopic Partial Nephrectomy in Treating Renal Angiomyolipoma. 38
28407628 2017
416
Ex-vivo partial nephrectomy after living donor nephrectomy: Surgical technique for expanding kidney donor pool. 38
28216945 2017
417
[IMPORTANCE OF SCREENING FOR LUNG LYMPHANGIOLEIOMYOMATOSIS AMONG RENAL ANGIOMYOLIPOMA CASES]. 38
30333440 2017
418
Laparoscopic Retroperitoneal Nephron-Sparing Surgery Without Renal Artery Clamping with Preoperative Selective Arterial Embolization for Management of Right Renal Angiomyolipoma of Diameter 10 cm: A Case Report. 38
28265590 2017
419
Pooled analysis of menstrual irregularities from three major clinical studies evaluating everolimus for the treatment of tuberous sclerosis complex. 38
29023494 2017
420
Treatment effect of mTOR-inhibition on tissue composition of renal angiomyolipomas in tuberous sclerosis complex (TSC). 38
29232371 2017
421
Imaging of tuberous sclerosis complex: a pictorial review. 38
28298732 2017
422
[Adrenal myelolipoma: about a case]. 38
29541300 2017
423
Lipomatous angiomyofibroblastoma of the vulva: A case report and review of the literature. 38
28123735 2017
424
The Risks of Renal Angiomyolipoma: Reviewing the Evidence. 38
29090118 2017
425
Small (< 4 cm) Renal Tumors With Predominantly Low Signal Intensity on T2-Weighted Images: Differentiation of Minimal-Fat Angiomyolipoma From Renal Cell Carcinoma. 38
27824487 2017
426
Loss of intratumoral macroscopic fat in renal angiomyolipoma following chemoradiation therapy for pancreatic cancer. 38
30363307 2017
427
Angiomyolipoma with Epithelial Cysts Masquerading as a Cystic Renal Cell Carcinoma. 38
28413382 2017
428
Everolimus long-term use in patients with tuberous sclerosis complex: Four-year update of the EXIST-2 study. 38
28792952 2017
429
CD68-Positive Cells in Hepatic Angiomyolipoma. 38
28030864 2017
430
Spontaneous rupture of renal angiomyolipoma during pregnancy. 38
28062422 2017
431
Renal angiomyolipoma bleeding in a patient with TSC2/PKD1 contiguous gene syndrome after 17 years of renal replacement therapy. 38
27595512 2017
432
Renal Epithelioid Angiomyolipoma Associated with Pulmonary Lymphangioleiomyomatosis: Imaging Findings. 38
28584685 2017
433
Giant renal Angiomyolipoma masquerading as a Wilms tumor. 38
28197035 2017
434
[Thermoablation therapy in the treatment of benign lesions]. 38
27989228 2016
435
[How we managed to treat minimally invasively in a hybrid operating room a 13cm large symptomatic renal angiomyolipoma with intra-tumoral hemorrhage]. 38
28279365 2016
436
Malignant hepatic epithelioid angiomyolipoma with recurrence in the lung 7 years after hepatectomy: a case report and literature review. 38
27037804 2016
437
Renal angiomyolipoma in Birt-Hogg-Dube syndrome: A case study supporting overlap with tuberous sclerosis complex. 38
27643397 2016
438
Re: Can Quantitative CT Texture Analysis be Used to Differentiate Fat-Poor Renal Angiomyolipoma from Renal Cell Carcinoma on Unenhanced CT Images? 38
27845102 2016
439
Pathological features and clinical associations of 58 small incidental angiomyolipomas of the kidney. 38
27544799 2016
440
The economic burden of tuberous sclerosis complex in UK patients with renal manifestations: a retrospective cohort study in the clinical practice research datalink (CPRD). 38
27310569 2016
441
Kidney ultrasound - what is important for a urologist? 38
28138408 2016
442
[Renal angiomyolipoma in a patient with tuberous sclerosis. Case report.] 38
28042793 2016
443
Renal Angiomyolipoma: Mid- to Long-Term Results Following Embolization with Onyx. 38
27468838 2016
444
[A Case of Angiomyolipoma Occurring in the Mesentery of the Transverse Colon and Treated Using Laparoscopic Excision]. 38
28133292 2016
445
Urgent transcatheter arterial embolization for the treatment of ruptured renal angiomyolipoma with spontaneous hemorrhage. 38
26133195 2016
446
Re: Natural History of Renal Angiomyolipoma (AML): Most Patients with Large AMLs >4cm can be Offered Active Surveillance as an Initial Management Strategy. 38
27751445 2016
447
Effect of delayed resection after initial surveillance and tumor growth rate on final surgical pathology in patients with small renal masses (SRMs). 38
27687544 2016
448
Efficacy and safety of Everolimus in children with TSC - associated epilepsy - Pilot data from an open single-center prospective study. 38
27809914 2016
449
Comparison of Biexponential and Monoexponential Model of Diffusion-Weighted Imaging for Distinguishing between Common Renal Cell Carcinoma and Fat Poor Angiomyolipoma. 38
27833401 2016
450
Spindle Cell Lipoma in an End-Stage Renal Allograft: Case Report. 38
27932168 2016
451
Renal neuroendocrine tumour and synchronous pancreas metastasis: histopathological diagnosis using prostatic acid phosphatase. 38
27803081 2016
452
Calcified Renal Angiomyolipoma: A Case Report. 38
27443470 2016
453
Laparoscopic surgery in great adrenal malignant masses. 38
27845698 2016
454
New radiologic classification of renal angiomyolipomas. 38
27666625 2016
455
Successful Pregnancy Outcome in a Patient with Solitary Kidney Affected by Angiomyolipoma: A Rare Case. 38
27891407 2016
456
Contrast-Enhanced Sonography and Fusion Technology for Assessment of an Embolized Renal Angiomyolipoma. 38
27672234 2016
457
[Diagnostic utility of immunohistochemistry in differential diagnosis of renal tumors with oncocytic features]. 38
27760610 2016
458
Renal epithelioid angiomyolipoma: Histopathologic review, immunohistochemical evaluation and prognostic significance. 38
27595761 2016
459
Contrast-Enhanced Ultrasonography with Quantitative Analysis allows Differentiation of Renal Tumor Histotypes. 38
27725761 2016
460
[Pulmonary lymphangioleiomyomatosis: From pathogenesis to management]. 38
26604019 2016
461
Renal Angiomyolipoma in Pregnancy: Surgical Management with Fetal Preservation - Approach in a Developing Setting. 38
28176962 2016
462
Editorial Comment to Outcomes of everolimus treatment for renal angiomyolipoma associated with tuberous sclerosis complex: A single institution experience in Japan. 38
27572892 2016
463
Outcomes of everolimus treatment for renal angiomyolipoma associated with tuberous sclerosis complex: A single institution experience in Japan. 38
27480662 2016
464
Management of Recurrent Retroperitoneal Sarcoma (RPS) in the Adult: A Consensus Approach from the Trans-Atlantic RPS Working Group. 38
27480354 2016
465
Incidence of mature adipocytic component within cutaneous smooth muscle neoplasms. 38
27404774 2016
466
The Angiomyolipoma Conundrum. 38
27670990 2016
467
Hepatic Angiomyolipoma Versus Hepatocellular Carcinoma in the Noncirrhotic Liver on Gadoxetic Acid-Enhanced MRI: A Diagnostic Challenge. 38
27248975 2016
468
Percutaneous radiofrequency ablation of renal tumors in high-risk patients: 10 years' experience. 38
27264790 2016
469
Expanding living kidney donor criteria with ex-vivo surgery for renal anomalies. 38
27800047 2016
470
Long-term Clinical Morbidity in Patients With Renal Angiomyolipoma Associated With Tuberous Sclerosis Complex. 38
27132503 2016
471
The impact of renal angiomyolipoma on estimated glomerular filtration rate in patients with tuberous sclerosis complex. 38
27710989 2016
472
A novel de novo mutation in the TSC2 gene in a Chinese patient with tuberous sclerosis complex. 38
27776463 2016
473
Uncommon liver tumors: Case report and literature review. 38
27684838 2016
474
Oncogenic effects of urotensin-II in cells lacking tuberous sclerosis complex-2. 38
27458154 2016
475
A Case Report of Ruptured Malignant Neuroendocrine Tumor of Kidney, an Extraordinary Presentation. 38
29927213 2016
476
Evaluation of T1-Weighted MRI to Detect Intratumoral Hemorrhage Within Papillary Renal Cell Carcinoma as a Feature Differentiating From Angiomyolipoma Without Visible Fat. 38
27275530 2016
477
Angiomyolipoma with minimal fat: differentiation of morphological and enhancement features from renal cell carcinoma at CT imaging. 38
26663389 2016
478
[Historic angiomyolipoma]. 38
27526985 2016
479
Laparoscopic Retroperitoneal Enucleation-Separation Surgery for Renal Angiomyolipoma: Perioperative and Oncologic Outcomes Based on a Randomized Controlled Trial. 38
27335234 2016
480
Small (<4 cm) Renal Mass: Differentiation of Angiomyolipoma without Visible Fat from Renal Cell Carcinoma Utilizing MR Imaging. 38
27429151 2016
481
Cytopathologic features of clear cell papillary renal cell carcinoma: A recently described variant to be considered in the differential diagnosis of clear cell renal epithelial neoplasms. 38
27062008 2016
482
Whole Exome Sequencing Identifies TSC1/TSC2 Biallelic Loss as the Primary and Sufficient Driver Event for Renal Angiomyolipoma Development. 38
27494029 2016
483
Giant bilateral sporadic renal angiomyolipoma. 38
27160876 2016
484
Coexistence of pulmonary lymphangioleiomyomatosis and pulmonary angiomyolipoma. 38
27527652 2016
485
MRI evaluation of small (<4cm) solid renal masses: multivariate modeling improves diagnostic accuracy for angiomyolipoma without visible fat compared to univariate analysis. 38
26486936 2016
486
Natural History of Renal Angiomyolipoma (AML): Most Patients with Large AMLs >4cm Can Be Offered Active Surveillance as an Initial Management Strategy. 38
26873836 2016
487
Evidence Supporting a Lymphatic Endothelium Origin for Angiomyolipoma, a TSC2(-) Tumor Related to Lymphangioleiomyomatosis. 38
27289491 2016
488
Rapamycin and rapalogs for tuberous sclerosis complex. 38
27409709 2016
489
Correlating Preoperative Imaging with Histologic Subtypes of Renal Cell Carcinoma and Common Mimickers. 38
27154238 2016
490
A case of renal cell carcinoma and angiomyolipoma in an adolescent girl. 38
27499406 2016
491
A Giant Intra Abdominal Mass Mimicking Renal Cell Carcinoma: A Rare Presentation of Renal Angiomyolipoma. 38
27612907 2016
492
Contrast-enhanced ultrasound in diagnosis of epithelioid renal angiomyolipoma with renal vein and inferior vena cava extension. 38
26960715 2016
493
Nephron Sparing Surgery Associated With Better Survival Than Radical Nephrectomy in Patients Treated for Unforeseen Benign Renal Tumors. 38
27017902 2016
494
A hitherto undescribed benign mesenchymal polyp of the gallbladder: edematous angiomyolipoma-like polyp. 38
27821035 2016
495
[Angiomyolipoma with Epithelial Cysts (AMLEC) of the Kidney]. 38
27569353 2016
496
Wünderlich ist nicht so Wunderbar: Bilateral Angiomyolipomas and Wünderlich Syndrome Requiring Emergency Embolization in a Patient without Tuberous Sclerosis. 38
27177703 2016
497
Hepatic epithelioid angiomyolipoma is a rare and potentially severe but treatable tumor: A report of three cases and review of the literature. 38
27313680 2016
498
CT negative attenuation pixel distribution and texture analysis for detection of fat in small angiomyolipoma on unenhanced CT. 38
27015866 2016
499
[Extrarenal Retroperitoneal Angiomyolipoma Masquerading as Retroperitoneal Liposarcoma : A Report of Two Cases]. 38
27452495 2016
500
Exosomes mediate the acquisition of the disease phenotypes by cells with normal genome in tuberous sclerosis complex. 38
26434588 2016
501
Intra-abdominal fat. Part III. Neoplasms lesions of the adipose tissue. 38
27446599 2016
502
Everolimus-induced near-resolution of giant cardiac rhabdomyomas and large renal angiomyolipoma in a newborn with tuberous sclerosis complex. 38
27055516 2016
503
An unusually large renal angiomyolipoma peeping into the right atrium. 38
27352862 2016
504
Angiomyolipoma With Epithelial Cysts. 38
27232352 2016
505
Pharmacokinetics and pharmacodynamics of everolimus in patients with renal angiomyolipoma and tuberous sclerosis complex or lymphangioleiomyomatosis. 38
26580489 2016
506
Renal involvement in tuberous sclerosis complex with emphasis on cystic lesions. 38
26219723 2016
507
Fat-containing Retroperitoneal Lesions: Imaging Characteristics, Localization, and Differential Diagnosis. 38
27163589 2016
508
Primary hepatic epithelioid angiomyolipoma: A malignant potential tumor which should be recognized. 38
27239117 2016
509
Natural history of mevalonate kinase deficiency: a literature review. 38
27142780 2016
510
Renal Angiomyolipoma With Sarcoid Granulomas: Report of a Unique Case. 38
26582772 2016
511
Renal cell carcinoma: A nomogram for the CT imaging-inclusive prediction of indolent, non-clear cell renal cortical tumours. 38
27016623 2016
512
Re: Small (< 4 cm) Renal Masses: Differentiation of Angiomyolipoma without Visible Fat from Renal Cell Carcinoma Using Unenhanced and Contrast-Enhanced CT. 38
27186724 2016
513
An Unusual Combination of Biliary Cystadenoma and Renal Angiomyolipoma- A Case Report. 38
27437238 2016
514
Aneurysm in a Large Sporadic Renal Angiomyolipoma. 38
27162594 2016
515
Diagnostic utility of Wilms' tumour-1 protein (WT-1) immunostaining in paediatric renal tumours. 38
27748279 2016
516
Role of 64 slice multidetector computed tomography and angiography to establish relationship between tumor size, aneurysm formation and spontaneous rupture of renal angiomyolipomas: Single center experience. 38
27141187 2016
517
Quantitative evaluation of contrast-enhanced ultrasound for differentiation of renal cell carcinoma subtypes and angiomyolipoma. 38
26971426 2016
518
The Role of mTOR Inhibitors in the Treatment of Patients with Tuberous Sclerosis Complex: Evidence-based and Expert Opinions. 38
26927950 2016
519
Update on the Diagnosis and Management of Renal Angiomyolipoma. 38
26612197 2016
520
Rapidly Progressing Malignant Epithelioid Renal Angiomyolipoma: A Case Report. 38
27085568 2016
521
Prospective Evaluation of (99m)Tc-sestamibi SPECT/CT for the Diagnosis of Renal Oncocytomas and Hybrid Oncocytic/Chromophobe Tumors. 38
26386607 2016
522
[Hepatic angiomyolipoma: a clinicopathologic features and prognosis analysis of 182 cases]. 38
26956960 2016
523
Lipid-poor renal angiomyolipoma: Differentiation from clear cell renal cell carcinoma using wash-in and washout characteristics on contrast-enhanced computed tomography. 38
26998171 2016
524
Robotic Partial Nephrectomy in the Treatment of Renal Angiomyolipoma. 38
26654096 2016
525
[Managing focal incidental renal lesions]. 38
26723224 2016
526
Observational Study of a French and Belgian Multicenter Cohort of 23 Patients Diagnosed in Adulthood With Mevalonate Kinase Deficiency. 38
26986117 2016
527
Angiomyolipoma of donor kidney: Successful transplantation and 5-year follow-up. 38
27051138 2016
528
Bilateral renal angiomyolipoma presenting as tuberous sclerosis syndrome. 38
26969365 2016
529
Percutaneous Microwave Ablation of Renal Angiomyolipomas. 38
26390876 2016
530
Aggressive Angiomyolipomas: the Clandestine Epithelioid Variant. 38
26989374 2016
531
Comparison of CT and contrast-enhanced ultrasound findings in hepatic angiomyolipoma with pathological correlations. 38
26867906 2016
532
Unenhanced CT and MRI Parameters That Can Be Used to Reliably Predict Fat-Invisible Angiomyolipoma. 38
26797361 2016
533
Angiomyolipoma (AML) without visible fat: Ultrasound, CT and MR imaging features with pathological correlation. 38
26032880 2016
534
Exophytic renal angiomyolipoma and perirenal liposarcoma: revisiting the role of CT for differential diagnosis. 38
25722461 2016
535
A Possible New Multiple Endocrine Neoplasia Mutation in a Patient with a Prototypic Multiple Endocrine Neoplasia Presentation. 38
26989398 2016
536
Juxtaglomerular cell tumor: A case report. 38
26893753 2016
537
[A clinical observation of cool-tip radiofrequency ablation assisted enucleation for giant renal angiomyolipoma]. 38
26876081 2016
538
Erratum to: Angiomyolipoma being surgically excised for presumed kidney carcinoma. 38
26681192 2016
539
Spontaneous rupture of a giant renal angiomyolipoma-Wunderlich's syndrome: Report of a case. 38
26764888 2016
540
HMB-45 negative angiomyolipoma of the orbit: a case report and review of the literature. 38
26754205 2016
541
Hemorrhagic Renal Angiomyolipoma in Pregnancy Effectively Managed by Immediate Cesarean Section and Elective Transcatheter Arterial Embolization: A Case Report. 38
27579420 2016
542
Combination of Superselective Arterial Embolization and Radiofrequency Ablation for the Treatment of a Giant Renal Angiomyolipoma Complicated with Caval Thrombus. 38
27293932 2016
543
Malignant renal epithelioid angiomyolipoma: A case report and review of the literature. 38
26870174 2016
544
Angiomyolipoma in a Patient with Situs Inversus Totalis: Managing Two Rare Diseases. 38
27525134 2016
545
[A Case of Renal Angiomyolipoma with Tumor Thrombus Invading the Inferior Vena Cava]. 38
26932331 2016
546
An Unusual Variant of Hepatic Inflammatory Angiomyolipoma: Report of a Rare Entity. 38
26927347 2016
547
Renal AML with inferior vena cava thrombus treated by workbench surgery and autotransplantation. 38
26360502 2016
548
EXUDATIVE RETINAL DETACHMENT AS THE PRESENTING FEATURE OF TUBEROUS SCLEROSIS COMPLEX. 38
26057258 2016
549
Analysis of a Mouse Skin Model of Tuberous Sclerosis Complex. 38
27907099 2016
550
Review of the Tuberous Sclerosis Renal Guidelines from the 2012 Consensus Conference: Current Data and Future Study. 38
27504842 2016
551
Activation of the ER stress and calcium signaling in angiomyolipoma. 38
27468872 2016
552
Long-Term Use of Everolimus in Patients with Tuberous Sclerosis Complex: Final Results from the EXIST-1 Study. 38
27351628 2016
553
HUGE RENAL ANGIOMYOLIPOMA (AML) IN TUBEROUS SCLEROSIS COMPLEX (TSC) WHICH IS CONTROLED BY EVEROLIMUS: A CASE REPORT. 38
28132993 2016
554
Everolimus for renal angiomyolipoma in patients with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis: extension of a randomized controlled trial. 38
26156073 2016
555
Lymphangioleiomyomatosis and multifocal micronodular pneumocyte hyperplasia in Japanese patients with tuberous sclerosis complex. 38
26718139 2016
556
Renal oncocytosis: a clinicopathological and cytogenetic study of 42 tumours occurring in 11 patients. 38
27020208 2016
557
Usefulness of diffusion tensor imaging for the differentiation between low-fat angiomyolipoma and clear cell carcinoma of the kidney. 38
26759751 2016
558
Epithelioid angiomyolipoma of the liver: Clinicopathological correlation in a series of 4 cases. 38
26765232 2016
559
Differentiation of Clear Cell Renal Cell Carcinoma From Other Subtypes and Fat-Poor Angiomyolipoma by Use of Quantitative Enhancement Measurement During Three-Phase MDCT. 38
26700359 2016
560
Incremental Expression of 14-3-3 Protein Beta/Alpha in Urine Correlates with Advanced Stage and Poor Survival in Patients with Clear Cell Renal Cell Carcinoma. 38
27039779 2016
561
Angiomyolipoma and Malignant PEComa: Discussion of Two Rare Adrenal Tumors. 38
26998374 2016
562
A Review of the Literature on Extrarenal Retroperitoneal Angiomyolipoma. 38
26989509 2016
563
Partial Nephrectomy for a Massive Sporadic Renal Angiomyolipoma: Case Report and Review of the Literature. 38
28070443 2016
564
[Renal epithelioid angiomyolipoma mimicking renal carcinoma]. 38
27642438 2016
565
[Diagnostic criteria and management options for renal angiomyolipoma: about 8 cases]. 38
28292144 2016
566
Renal angiomyolipoma with renal vein thrombosis: an incidental finding. 38
30363498 2016
567
Not All Acute Abdomen Cases in Early Pregnancy Are Ectopic; Expect the Unexpected: Renal Angiomyolipoma Causing Massive Retroperitoneal Haemorrhage. 38
27429809 2016
568
Angiomyolipoma of the rib: A rare case report. 38
26870370 2016
569
Use of DWI in the Differentiation of Renal Cortical Tumors. 38
26700340 2016
570
Using a Harmonic Scalpel "Drilling and Clamping" Method to Implement Zero Ischemic Robotic-assisted Partial Nephrectomy: An Observation Case Report Study. 38
26817867 2016
571
Long-Term Recurrence of Renal Angiomyolipoma Angiogenic Component after Ethylene Vinyl Alcohol Copolymer Embolization. 38
26596186 2015
572
Small (< 4 cm) Renal Masses: Differentiation of Angiomyolipoma Without Visible Fat From Renal Cell Carcinoma Using Unenhanced and Contrast-Enhanced CT. 38
26587925 2015
573
Preoperative evaluation of renal cell carcinoma by using 18F-FDG PET/CT. 38
26164183 2015
574
Response to everolimus is seen in TSC-associated SEGAs and angiomyolipomas independent of mutation type and site in TSC1 and TSC2. 38
25782670 2015
575
Angioleiomyoma of the Sinonasal Tract: Analysis of 16 Cases and Review of the Literature. 38
26047608 2015
576
A 4-year prospective evaluation of protocols to improve clinical outcomes for patients with lymphangioleiomyomatosis in a national clinical centre. 38
26123659 2015
577
Hepatic angiomyolipoma: differential diagnosis from other liver tumors in a special reference to vascular imaging - importance of early drainage vein. 38
26943379 2015
578
Spontaneous rupture of renal angiomyolipoma in the third trimester. 38
26701006 2015
579
Treatment of renal angiomyolipoma: pooled analysis of individual patient data. 38
26710923 2015
580
A Case of Exophytic Angiomyolipoma of the Liver. 38
26730108 2015
581
Angiomyolipoma with epithelial cysts: Add one to the differential of cystic renal lesions. 38
26303457 2015
582
Angiomyolipoma with epithelial cyst (AMLEC): A rare variant of fat poor angiomyolipoma mimicking malignant cystic mass on MR imaging. 38
25921627 2015
583
[Diagnostic utility of S100A1, GLUT-1 and Caveolin-1 in renal tumors with oncocytic features: a comparative study]. 38
26888385 2015
584
Xp11.2 translocation renal cell carcinoma with egg-shell calcification mimicking a benign renal tumour: A case report. 38
26722310 2015
585
[Renal Epithelioid Angiomyolipoma with Spontaneous Rupture: A Case Report]. 38
26699887 2015
586
Total nephrectomy with nephron-sparing surgery for a giant bilateral renal angiomyolipoma: A case report. 38
26622869 2015
587
Diagnostic utility of diffusion-weighted magnetic resonance imaging in two common renal tumors. 38
26622890 2015
588
Quantitative assessment of solid renal masses by contrast-enhanced ultrasound with time-intensity curves: how we do it. 38
26036794 2015
589
Imaging of adrenal and renal hemorrhage. 38
26036792 2015
590
A suggestion for pathological grossing and reporting based on prognostic indicators of malignancies from a pooled analysis of renal epithelioid angiomyolipoma. 38
26271644 2015
591
PEComa: morphology and genetics of a complex tumor family. 38
26144278 2015
592
Tuberous Sclerosis Complex: State-of-the-Art Review with a Focus on Pulmonary Involvement. 38
26104489 2015
593
Long-term Follow-up Assessing Renal Angiomyolipoma Treatment Patterns, Morbidity, and Mortality: An Observational Study in Tuberous Sclerosis Complex Patients in the Netherlands. 38
26165440 2015
594
Tuberous sclerosis complex: the past and the future. 38
25533384 2015
595
Epithelioid angiomyolipoma mimicking adrenal cortical carcinoma: A diagnostic pitfall. 38
26622807 2015
596
Laparoscopic excision of infra-renal PEComa. 38
26622123 2015
597
Malignant presentation of uterine lymphangioleiomyomatosis. 38
26522119 2015
598
Incidental Nodal Lymphangioleiomyomatosis Is Not a Harbinger of Pulmonary Lymphangioleiomyomatosis: A Study of 19 Cases With Evaluation of Diagnostic Immunohistochemistry. 38
26135558 2015
599
Diffuse fatty metamorphosis of a large, well-differentiated hepatocellular carcinoma originating in the normal liver: a case report and literature review. 38
26416601 2015
600
Multidetector Computed Tomography Features in Differentiating Exophytic Renal Angiomyolipoma from Retroperitoneal Liposarcoma: A Strobe-Compliant Observational Study. 38
26376398 2015
601
The "peripheral washout sign" in focal hepatic lesions: not always an MRI sign of malignancy. 38
25951769 2015
602
The Role of Transarterial Embolization in the Treatment of Renal Tumors. 38
26768635 2015
603
Differentiation of Renal Tumor Histotypes: Usefulness of Quantitative Analysis of Contrast-Enhanced Ultrasound. 38
26295670 2015
604
Accuracy of Contrast-enhanced US for Differentiating Benign from Malignant Solid Small Renal Masses. 38
25919803 2015
605
Diagnostically Challenging "Fatty" Retroperitoneal Tumors. 38
26297062 2015
606
Role of immunohistochemistry and fluorescence in-situ hybridization (FISH) in the diagnosis of spindle and round cell tumors of the kidney. 38
25976281 2015
607
Enteroenteric intussusception in an adult caused by an ileal angiomyolipoma. 38
26543292 2015
608
Does Computer-Aided Diagnosis Permit Differentiation of Angiomyolipoma Without Visible Fat From Renal Cell Carcinoma on MDCT? 38
26295666 2015
609
Can Quantitative CT Texture Analysis be Used to Differentiate Fat-poor Renal Angiomyolipoma from Renal Cell Carcinoma on Unenhanced CT Images? 38
25906183 2015
610
Successful treatment with sirolimus for an angiomyolipoma mimicking renal cell carcinoma in a transplanted kidney. 38
25790294 2015
611
Angiomyolipoma with minimal fat: differentiation from clear cell renal cell carcinoma and papillary renal cell carcinoma by texture analysis on CT images. 38
26031228 2015
612
A Case Series & Review of Literature of Angiomyolipoma with Medical & Surgical Perspective. 38
26500947 2015
613
The Application of "Renal Pedicle Rotation" Method in Retroperitoneal Laparoscopic Partial Nephrectomy for Renal Ventral Tumors. 38
26136149 2015
614
CT-imaging features of renal epithelioid angiomyolipoma. 38
26391670 2015
615
Transarterial Embolization of Angiomyolipoma: A Systematic Review. 38
25916674 2015
616
Lymphangioleiomyomatosis Presenting with Perirenal Hemorrhage. 38
30039066 2015
617
An Unusual Manifestation of Renal Angiomyolipoma: Pulmonary Fat Embolism. 38
26166674 2015
618
Gd-EOB-DTPA-enhanced and diffusion-weighted magnetic resonance findings in hepatic epithelioid angiomyolipoma: A case report. 38
26622641 2015
619
Granulomatous reaction in hepatic inflammatory angiomyolipoma after chemoembolization and spontaneous rupture. 38
26327777 2015
620
The diagnostic value of contrast-enhanced ultrasound in differentiating small renal carcinoma and angiomyolipoma. 38
26268710 2015
621
Renal Angiomyolipoma With Caval Extension and Pulmonary Fat Embolism: A Case Report. 38
26252271 2015
622
Fat-poor angiomyolipoma with cyst-like changes mimicking a cystic renal cell carcinoma: a case report. 38
26282684 2015
623
Differentiation of Sporadic Versus Tuberous Sclerosis Complex-Associated Angiomyolipoma. 38
26204278 2015
624
Rapamycin and its analogues (rapalogs) for Tuberous Sclerosis Complex-associated tumors: a systematic review on non-randomized studies using meta-analysis. 38
26259610 2015
625
Incidental Pelvic and Para-aortic Lymph Node Lymphangioleiomyomatosis Detected During Surgical Staging of Pelvic Cancer in Women Without Symptomatic Pulmonary Lymphangioleiomyomatosis or Tuberous Sclerosis Complex. 38
25786086 2015
626
Rates of interventional procedures in patients with tuberous sclerosis complex-related renal angiomyolipoma. 38
26073843 2015
627
Pericyte antigens in angiomyolipoma and PEComa family tumors. 38
26123600 2015
628
Bilateral Multifocal Renal Angiomyolipoma Associated with Wunderlich's Syndrome in A Tuberous Sclerosis Patient. 38
26435953 2015
629
[Renal angiomyolipoma with spontaneous retroperitoneal bleeding]. 38
26320358 2015
630
Interventional treatment of renal angiomyolipoma: immediate results and clinical and radiological follow-up of 4.5 years. 38
26346549 2015
631
Renal colic due to fatty tissue obstruction of the ureter following selective arterial embolisation of a 10 cm angiomyolipoma. 38
26224660 2015
632
Spontaneous rupture of a renal angiomyolipoma at 25 weeks of pregnancy treated with transarterial embolization: A case report and review of the literature. 38
25881870 2015
633
Editorial Comment to Spontaneous rupture of a renal angiomyolipoma at 25 weeks of pregnancy treated with transarterial embolization: A case report and review of the literature. 38
25904214 2015
634
Pulmonary choriostoma in a case of tuberous sclerosis complex. 38
26119439 2015
635
Isolated angiomyolipoma of vulva: A case report of an uncommon tumor at an uncommon site. 38
26458597 2015
636
Composite renal cell carcinoma and angiomyolipoma in a patient with Tuberous sclerosis: A diagnostic dilemma. 38
26279726 2015
637
Predictive Value of Chemical-Shift MRI in Distinguishing Clear Cell Renal Cell Carcinoma From Non-Clear Cell Renal Cell Carcinoma and Minimal-Fat Angiomyolipoma. 38
26102422 2015
638
[Epithelioid Angiomyolipoma of the Kidney: A Case Report]. 38
26278211 2015
639
Malignant epitheloid angiomyolipoma of the kidney in a child treated with sunitinib, everolimus and axitinib. 38
26279736 2015
640
Pediatric multifocal liver lesions evaluated by MRI. 38
26288526 2015
641
Minimal fat renal angiomyolipoma with lymph node involvement: A case report and literature review. 38
26609336 2015
642
Angiomyolipoma being surgically excised for presumed kidney carcinoma. 38
25940032 2015
643
Maxillary sinus angiomyolipoma: A case report and overview. 38
26214671 2015
644
Malignant perivascular epithelioid cell neoplasm of the mediastinum and the lung: one case report. 38
26039123 2015
645
Tumor necrosis after preventive embolization of large renal angiomyolipomas. 38
25823980 2015
646
High 18F-Fluorodeoxyglucose Uptake in Adrenal Angiomyolipoma: Case Report and Review of Literature. 38
26039121 2015
647
Cystic Angiomyolipoma Mimicking Cystic Renal Cell Carcinoma on Computed Tomography Image. 38
25865114 2015
648
Primary mesenchymal liver tumors: radiological spectrum, differential diagnosis, and pathologic correlation. 38
25311993 2015
649
Insight into response to mTOR inhibition when PKD1 and TSC2 are mutated. 38
26077033 2015
650
Renal angiomyolipoma during pregnancy: Case report and literature review. 38
28913054 2015
651
Primitive neuroectodermal tumour of the kidney: An unusual case mimicking renal angiomyolipoma with minimal fat. 38
26029311 2015
652
A Four-Year Follow-up Study of Renal Epithelioid Angiomyolipoma: A Multi-Center Experience and Literature Review. 38
25939249 2015
653
[Non-traumatic spontaneous retroperitoneal bleeding: the effect of an early and accurate diagnosis]. 38
26055286 2015
654
Cutaneous angiomyolipoma masquerading as a neurofibroma in a child with neurofibromatosis type 1: a case report. 38
25640861 2015
655
Lung adenocarcinoma metastasizing into a renal angiomyolipoma. 38
25691390 2015
656
Use of sirolimus in the treatment of lymphangioleiomyomatosis: favorable responses in patients with different extrapulmonary manifestations. 38
26176526 2015
657
High success rate after arterial renal embolisation. 38
26050825 2015
658
Improving recognition of hepatic perivascular epithelioid cell tumor: Case report and literature review. 38
25954119 2015
659
Malignant renal epithelioid angiomyolipoma associated with abdominopelvic hydatid cysts: a case report. 38
25890370 2015
660
Pigmented Epithelioid Angiomyolipoma of the Kidney. 38
26118214 2015
661
Can radiologists and urologists reliably determine renal mass histology using standard preoperative computed tomography imaging? 38
25222030 2015
662
[Intravoxel incoherent motion dwi in renal tumors: differentiation between benign and malignant masses]. 38
26081359 2015
663
Complications of mammalian target of rapamycin inhibitor anticancer treatment among patients with tuberous sclerosis complex are common and occasionally life-threatening. 38
25719621 2015
664
Safety considerations of mammalian target of rapamycin inhibitors in tuberous sclerosis complex and renal transplantation. 38
25402866 2015
665
Emergency embolization of actively bleeding small renal angiomyolipoma with a fast growth in four months. 38
25907893 2015
666
Alterations of the mTOR pathway in hepatic angiomyolipoma with emphasis on the epithelioid variant and loss of heterogeneity of TSC1/TSC2. 38
25234729 2015
667
Rupture of renal angiomyolipoma during childbirth. 38
25669735 2015
668
Giant exophytic renal angiomyolipoma mimicking as retroperitoneal sarcoma; a case report with review of literature. 38
26023631 2015
669
[Renal angiomyolipoma with inferior vena cava thrombosis during pregnancy]. 38
25638747 2015
670
Robotic-assisted partial nephrectomy: experience on 60 cases. 38
25589026 2015
671
Use of oestrogen-containing medication is not associated with renal angiomyolipoma in tuberous sclerosis: findings from a survey. 38
25737072 2015
672
Qualitative and quantitative analysis with contrast-enhanced ultrasonography: diagnosis value in hypoechoic renal angiomyolipoma. 38
25741195 2015
673
Multiparametric MRI of solid renal masses: pearls and pitfalls. 38
25472466 2015
674
Computed tomographic features of lymphangioleiomyomatosis: evaluation in 138 patients. 38
25544557 2015
675
PEComas of the kidney and of the genitourinary tract. 38
25804448 2015
676
Liver transplantation for recurrent posthepatectomy malignant hepatic angiomyolipoma: a case report. 38
25834347 2015
677
Hepatocellular carcinoma with concomitant hepatic angiomyolipoma and cavernous hemangioma in one patient. 38
25805953 2015
678
Differentiation of lipid poor angiomyolipoma from hepatocellular carcinoma on gadoxetic acid-enhanced liver MR imaging. 38
25231411 2015
679
Renal angiomyolipoma: preoperative identification of atypical fat-poor AML. 38
25677233 2015
680
Clinical outcomes of patients with nondiagnostic biopsy during cryoablation of small renal masses. 38
25733273 2015
681
[Pulmonary lymphangioleiomyomatosis with renal angiomyolipoma: report of a case]. 38
26268761 2015
682
Renal leiomyoma: a contemporary multi-institution study of an infrequent and frequently misclassified neoplasm. 38
25517956 2015
683
Fat-suppressed T2-weight